<?php
function _get_node_export_nodes_one() {
return array(
  array(
    'nid' => '61335',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366989664',
    'changed' => '1367355007',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61335',
    'revision_uid' => '1',
    'title' => 'article16_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367355007',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article160413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13705',
        'uid' => '5392',
        'filename' => 'article16_0413.html',
        'filepath' => 'sites/default/files/article16_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '31324',
        'status' => '1',
        'timestamp' => '1366989664',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Gemcitabine (GEM) is widely used as a chemotherapeutic agent. However, pulmonary toxicity has been rarely observed with GEM use. This article aims to determine the incidence and causes of drug-induced pulmonary toxicity, and to classify the high-resolution computed tomography (HRCT) findings for antitumor therapy-associated pulmonary toxicity based on characteristic patterns and pathological considerations, with a special focus on GEM-associated pulmonary toxicity (GAPT).

Methods. Medical records of all patients with drug-induced pulmonary toxicity seen at Kyorin University hospital between April 2006 and December 2011 were retrospectively reviewed. The study examined correlations between HRCT and the assessed pathological or clinical findings, with a specific focus on antitumor drugs.

Results. We identified 66 patients with drug-induced pulmonary toxicity. Among the antitumor drugs, GEM was the primary offending agent (n = 8) for pulmonary toxicity followed by docetaxel and gefitinib. HRCT patterns for the eight GAPT patients included the non-specific interstitial pneumonia (NSIP; n = 5) and the hypersensitivity pneumonitis (HP)-like pattern (n = 3). In contrast, four patients in the study were found to have the HP-like pattern, with three cases associated with GEM and one case associated with imatinib mesylate. The transbronchial lung biopsy or video-assisted thoracic surgery specimens for these patients showed granuloma or organizing tissue with a random distribution that was independent of the respiratory bronchiole. These results appeared to correspond to the HRCT-determined centrilobular nodules.

Conclusion. GEM was the leading cause of drug-induced pulmonary toxicity in the patients examined in this study. This toxicity appears as NSIP or an HP-like pattern during HRCT examinations. This HP-like pattern may be useful for diagnosing GEM-induced pulmonary toxicity, as well as demonstrating granuloma or organizing tissue during lung pathology examinations.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Masaki Tamura, Takeshi Saraya, Masachika Fujiwara, Sayuki Hiraoka, Takuma Yokoyama, Kinuko Yano, Haruyuki Ishii, Junji Furuse, Tomoyuki Goya, Hajime Takizawa, Hajime Goto',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '153404',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13568',
        'uid' => '5392',
        'filename' => 'onc9991112290001.jpg',
        'filepath' => 'sites/default/files/onc9991112290001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34307',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13569',
        'uid' => '5392',
        'filename' => 'onc9991112290002.jpg',
        'filepath' => 'sites/default/files/onc9991112290002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '31199',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13570',
        'uid' => '5392',
        'filename' => 'onc9991112290003.jpg',
        'filepath' => 'sites/default/files/onc9991112290003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '56574',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366989664',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61333',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366989539',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61333',
    'revision_uid' => '1',
    'title' => 'article15_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article150413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13704',
        'uid' => '5392',
        'filename' => 'article15_0413.html',
        'filepath' => 'sites/default/files/article15_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '50533',
        'status' => '1',
        'timestamp' => '1366989539',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Objective. Treatment with anthracyclines may cause cardiac dysfunction, but the sequence of anthracycline-induced heart lesions has been incompletely characterized. NADPH oxidase, a key mediator of oxidative cardiac damage and remodeling, modulates anthracycline clinical cardiotoxicity. Our aim was to determine which cardiac histological lesions are specifically induced by anthracycline treatment and to investigate the role of NADPH functional genetic polymorphisms in their development.

Patients and Methods. Using a retrospective case-control design, we evaluated cardiac histological lesions and NADPH genotype (polymorphisms rs1883112, rs4673, and rs13058338) in 97 consecutive decedents with a cancer diagnosis (48 treated with anthracyclines).

Results. Myocytolysis (60%), patched myocardial necrosis (19%), and myocardial fibrosis (diffuse and patched; 62% and 23%, respectively) were associated with anthracycline treatment. In patients receiving anthracyclines, NADPH oxidase polymorphism rs4673 protected against focal myocardial necrosis (odds ratio [OR], 0.11; 95% confidence interval [CI], 0.20-0.63) whereas rs1883112 was strongly associated with cardiac fibrosis (OR, 5.11; 95% CI, 1.59-16.43), which was present in all homozygotes.

Conclusion. Anthracyclines induce a cardiac remodeling pattern characterized by interstitial or patched fibrosis. The contribution of the functionally relevant NADPH polymorphisms rs1883112 and rs4673 to anthracycline-related heart lesions provides a plausible explanation for their modulation of cardiotoxicity. If confirmed, these findings may lead to better individualized strategies for early detection and prevention of anthracycline cardiotoxicity.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Almudena Cascales, Francisco Pastor-Quirante, Beatriz Sánchez-Vega, Ginés Luengo-Gil, Javier Corral, Guzmán Ortuño-Pacheco, Vicente Vicente, Francisco Ayala de la Peña',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '131530',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13564',
        'uid' => '5392',
        'filename' => 'onc9991112650001.jpg',
        'filepath' => 'sites/default/files/onc9991112650001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '57713',
        'status' => '1',
        'timestamp' => '1366750281',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13565',
        'uid' => '5392',
        'filename' => 'onc9991112650002.jpg',
        'filepath' => 'sites/default/files/onc9991112650002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '23284',
        'status' => '1',
        'timestamp' => '1366750281',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366989539',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61331',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366989393',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61331',
    'revision_uid' => '1',
    'title' => 'article14_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article140413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13703',
        'uid' => '5392',
        'filename' => 'article14_0413.html',
        'filepath' => 'sites/default/files/article14_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '41615',
        'status' => '1',
        'timestamp' => '1366989393',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Amrubicin, a third-generation synthetic anthracycline agent, has favorable clinical activity and acceptable toxicity for the treatment of patients with non-small cell lung cancer (NSCLC) and small cell lung cancer. We conducted this study to evaluate the efficacy and safety of amrubicin for advanced NSCLC patients as a third- or fourth-line therapy. Eligible patients had recurrent or refractory advanced NSCLC after second- or third-line therapy. Patients received amrubicin, 35 mg/m2 i.v. on days 1-3 every 3 weeks. The primary endpoint was the disease control rate (DCR). Secondary endpoints were the overall survival (OS) time, progression-free survival (PFS) time, response rate, and toxicity profile. Of the 41 patients enrolled, 26 received amrubicin as a third-line and 15 received it as a fourth-line therapy. The median number of treatment cycles was two (range, 1-9). Objective responses were complete response (n = 0), partial response (n = 4), stable disease (n = 21), progressive disease (n = 15), and not evaluable (n = 1), resulting in a DCR of 61.0% (95% confidence interval, 46.0%-75.9%). The overall response rate was 9.8% (95% confidence interval, 0.6%-18.8%). The median PFS interval was 3.0 months, median OS time was 12.6 months, and 1-year survival rate was 53.7%. Grade 3 or 4 hematological toxicities were neutropenia (68%), anemia (12%), thrombocytopenia (12%), and febrile neutropenia (17%). Nonhematological toxicities were mild and reversible. No treatment-related deaths were observed. Amrubicin showed significant clinical activity with manageable toxicities as a third- or fourth-line therapy for patients with advanced NSCLC. This study provides relevant data for routine practice and future prospective trials evaluating third- or fourth-line treatment strategies for patients with advanced NSCLC.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, Kei Takamura, Eiki Kikuchi, Tomoya Kuda, Shunichi Sugawara, Aya Suzuki, Makoto Maemondo, Yuka Fujita, Ichiro Kinoshita, Akira Inoue, Fumihiro Hommura, Yutaka Katsuura, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura, Hokkaido Lung Cancer Clinical Study Group',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '66767',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13560',
        'uid' => '5392',
        'filename' => 'onc9991112660001.jpg',
        'filepath' => 'sites/default/files/onc9991112660001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '11462',
        'status' => '1',
        'timestamp' => '1366742183',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13561',
        'uid' => '5392',
        'filename' => 'onc9991112660002.jpg',
        'filepath' => 'sites/default/files/onc9991112660002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13690',
        'status' => '1',
        'timestamp' => '1366742183',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366989393',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61330',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366989087',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61330',
    'revision_uid' => '1',
    'title' => 'article13_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article130413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13702',
        'uid' => '5392',
        'filename' => 'article13_0413.html',
        'filepath' => 'sites/default/files/article13_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '60808',
        'status' => '1',
        'timestamp' => '1366989087',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Antiangiogenic Therapies for Advanced Hepatocellular Carcinoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Hepatocellular carcinoma (HCC) is a significant cause of death worldwide. HCC is a highly vascular tumor, and proangiogenic cytokines such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor may play crucial roles in this disease. Sorafenib, a multikinase inhibitor that blocks VEGF and PDGF signaling, was the first systemic therapy to demonstrate improved survival in patients with advanced HCC. Several other drugs targeting VEGF are in development. Because of the anticipation of eventual resistance to anti-VEGF therapies, drugs that also target alternative proangiogenic pathways are being investigated. Recent clinical and preclinical data along with ongoing studies are reviewed.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Keeran R. Sampat, Bert O\'Neil',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '95103',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13557',
        'uid' => '5392',
        'filename' => 'onc9991112900001.jpg',
        'filepath' => 'sites/default/files/onc9991112900001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34295',
        'status' => '1',
        'timestamp' => '1366731936',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sto.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366989087',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61329',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366988975',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61329',
    'revision_uid' => '1',
    'title' => 'article6_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article60413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13701',
        'uid' => '5392',
        'filename' => 'article6_0413.html',
        'filepath' => 'sites/default/files/article6_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '6559',
        'status' => '1',
        'timestamp' => '1366988975',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Sorafenib has proven survival benefits in patients with advanced hepatocellular carcinoma (HCC). The viability of continuing sorafenib at a higher dosage in patients who experienced radiologic disease progression was investigated.

Methods. Patients who experienced disease progression while on sorafenib 400 mg twice daily were randomized to sorafenib 600 mg twice daily (n = 49) or best supportive care (n = 52). The primary end point was progression-free survival (PFS). Time to progression, overall survival, and safety were also evaluated.

Results. The study did not meet its primary end point. The difference in PFS between the sorafenib arm (3.91 months) and the best supportive care arm (2.69 months) did not reach statistical significance (p = 0.086). Adverse events were mainly grade 1-2 and similar across both groups. In the sorafenib arm, the most frequent events were diarrhea (80%), weight loss (75%), fatigue (67%), hand-foot-skin reaction (49%), abdominal pain (37%), and stomatitis (26%).

Conclusions. Escalated-dose sorafenib in patients with advanced HCC who progressed while on sorafenib, failed to provide any clinical benefit. Second-line treatment still remains an open issue to be explored in appropriate clinical trials.
',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Lorenza Rimassa, Tiziana Pressiani, Corrado Boni, Carlo Carnaghi, Elena Rota Caremoli, Stefano Fagiuoli, Paolo Foa, Stefania Salvagni, Enrico Cortesi, Maria Chiara Tronconi, Nicola Personeni, Silvia Bozzarelli, Maria Chiara Banzi, Silvia Fanello, Fabio Romano Lutman, Laura Giordano, Armando Santoro',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '22319',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13539',
        'uid' => '5392',
        'filename' => 'onc0041313380001.jpg',
        'filepath' => 'sites/default/files/onc0041313380001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '15760',
        'status' => '1',
        'timestamp' => '1366664194',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366988975',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61328',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366988873',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61328',
    'revision_uid' => '1',
    'title' => 'article5_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article50413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13698',
        'uid' => '5392',
        'filename' => 'article5_0413.html',
        'filepath' => 'sites/default/files/article5_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '7520',
        'status' => '1',
        'timestamp' => '1366988873',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Treatments that target the vascular endothelial growth factor (VEGF) pathway have efficacy in colorectal cancer. We evaluated tolerability and efficacy of tivozanib (an oral VEGF receptor-1, -2, -3 inhibitor) plus everolimus (an oral mammalian target of rapamycin inhibitor).


Methods. The phase Ib study followed a 3 + 3 dose-escalation design with three dose levels. The primary objective in the follow-on phase II study was improvement in 2-month progression-free survival (PFS) from 30% (historical benchmark) to 50% in patients with refractory, metastatic colorectal cancer.


Results. Dose-limiting toxicities in the phase Ib study were grade 3 fatigue and dehydration. Oral tivozanib (1 mg daily for 3 of 4 weeks) and oral everolimus (10 mg daily continuously) were advanced to a 40-patient phase II study. The most common grade 3-4 adverse events were thrombocytopenia and hypophosphatemia. The 2-month PFS rate was 50%, with 20 of 40 patients having stable disease (SD). Seven (18%) patients were treated for ≥6 months. Median PFS and overall survival (OS) times were 3.0 months (95% confidence interval [CI]: 1.9-3.6 months) and 5.6 months (95% CI: 4.4-10.6 months), respectively. Patients who developed grade 1+ hypertension had increased SD rates (65.2% vs. 29.4%) and longer OS times (10.6 vs. 3.7 months).


Conclusions. The oral combination of tivozanib and everolimus was well tolerated, with stable disease achieved in 50% of patients with refractory, metastatic colorectal cancer.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Brian M. Wolpin, Kimmie Ng, Andrew X. Zhu, Thomas Abrams, Peter C. Enzinger, Nadine J. McCleary, Deborah Schrag, Eunice L. Kwak, Jill N. Allen, Pankaj Bhargava, Jennifer A. Chan, Wolfram Goessling, Lawrence S. Blaszkowsky, Jeffrey G. Supko, Meaghan Elliot, Kaori Sato, Eileen Regan, Jeffrey A. Meyerhardt, Charles S. Fuchs',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '25229',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13536',
        'uid' => '5392',
        'filename' => 'onc0041313230001.jpg',
        'filepath' => 'sites/default/files/onc0041313230001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '17709',
        'status' => '1',
        'timestamp' => '1366663755',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366988873',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61327',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366988783',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61327',
    'revision_uid' => '1',
    'title' => 'article2_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article20413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13697',
        'uid' => '5392',
        'filename' => 'article2_0413.html',
        'filepath' => 'sites/default/files/article2_0413_1.html',
        'filemime' => 'text/html',
        'filesize' => '52407',
        'status' => '1',
        'timestamp' => '1366988783',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. The purpose of the study was to estimate the impact on survival and fracture rates of the use of zoledronic acid versus no use (or delayed use) in the adjuvant treatment of patients with early-stage (stages I-III) breast cancer.

Materials and Methods. We performed a systematic review and meta-analysis of randomized clinical trials. Trials were located through PubMed, ISI, Cochrane Library, and major cancer scientific meeting searches. All trials that randomized patients with primary breast cancer to undergo adjuvant treatment with zoledronic acid versus nonuse, placebo, or delayed use of zoledronic acid as treatment to individuals who develop osteoporosis were considered eligible. Standard meta-analytic procedures were used to analyze the study outcomes.

Results. Fifteen studies were considered eligible and were further analyzed. The use of zoledronic acid resulted in a statistically significant better overall survival outcome (five studies, 6,414 patients; hazard ratio [HR], 0.81; 95% confidence interval [CI], 0.70-0.94). No significant differences were found for the disease-free survival outcome (seven studies, 7,541 patients; HR, 0.86; 95% CI, 0.70-1.06) or incidence of bone metastases (seven studies, 7,543 patients; odds ratio [OR], 0.94; 95% CI, 0.64-1.37). Treatment with zoledronic acid led to a significantly lower overall fracture rate (OR, 0.78; 95% CI, 0.63-0.96). Finally, the rate of osteonecrosis of the jaw was 0.52%.

Conclusion. Zoledronic acid as adjuvant therapy in breast cancer patients appears to not only reduce the fracture risk but also offer a survival benefit over placebo or no treatment.

Implications for Practice: Zoledronic acid appears to have a role in adjuvant therapy in patients with breast cancer because it reduces the fracture rate and seems to offer survival benefits. The need for additional research is essential to determine if its effect is enhanced in low-estrogen environments and to reveal the magnitude of interaction between estrogen levels and zoledronic acid. Meanwhile, in patients with signs of bone loss (osteopenia or osteoporosis) during adjuvant endocrine therapy when the initiation of bisphosphonates is indicated, zoledronic acid might be preferred over other therapies due to its beneficial effect on survival.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Antonis Valachis, Nikolaos P. Polyzos, Robert E. Coleman, Michael Gnant, Holger Eidtmann, Adam M. Brufsky, Rebecca Aft, Amye J. Tevaarwerk, Karen Swenson, Pehr Lind, Davide Mauri',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '208994',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13525',
        'uid' => '5392',
        'filename' => 'onc9991112540001.jpg',
        'filepath' => 'sites/default/files/onc9991112540001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '29099',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13526',
        'uid' => '5392',
        'filename' => 'onc9991112540002.jpg',
        'filepath' => 'sites/default/files/onc9991112540002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '39597',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13527',
        'uid' => '5392',
        'filename' => 'onc9991112540003.jpg',
        'filepath' => 'sites/default/files/onc9991112540003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '44542',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13528',
        'uid' => '5392',
        'filename' => 'onc9991112540004.jpg',
        'filepath' => 'sites/default/files/onc9991112540004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '43349',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366988783',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61326',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366988640',
    'changed' => '1367357275',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61326',
    'revision_uid' => '1',
    'title' => 'article1_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357275',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article10413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13695',
        'uid' => '5392',
        'filename' => 'article1_0413.html',
        'filepath' => 'sites/default/files/article1_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '17874',
        'status' => '1',
        'timestamp' => '1366988640',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Screening for Breast Cancer-Related Lymphedema: The Need for Standardization',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'With an overall survival rate of 90% following treatment for breast cancer, post-treatment management has been increasingly focused on sequelae that negatively affect quality of life. Breast cancer-related lymphedema (BCRL) has long been recognized as a dreaded side effect of treatment; it can result in disfigurement, altered body image, pain, functional impairment, and emotional distress (Fig. 1) [1,2,3 ]. The risk of developing BCRL lasts for a lifetime, and the financial implications and burden of caring for this condition are well documented and significant [4,5 ].',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Jean O\'Toole, Lauren S. Jammallo, Cynthia L. Miller, Melissa N. Skolny, Michelle C. Specht, Alphonse G. Taghian',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '81379',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13520',
        'uid' => '5392',
        'filename' => 'onc9991112820001.jpg',
        'filepath' => 'sites/default/files/onc9991112820001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24319',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13521',
        'uid' => '5392',
        'filename' => 'onc9991112820002.jpg',
        'filepath' => 'sites/default/files/onc9991112820002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '29810',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13522',
        'uid' => '5392',
        'filename' => 'onc9991112820003.jpg',
        'filepath' => 'sites/default/files/onc9991112820003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '9376',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366988640',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61056',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366751265',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61056',
    'revision_uid' => '1',
    'title' => 'article19_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article190413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13577',
        'uid' => '5392',
        'filename' => 'article19_0413.html',
        'filepath' => 'sites/default/files/article19_0413.html',
        'filemime' => 'text/html',
        'filesize' => '55217',
        'status' => '1',
        'timestamp' => '1366751265',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Impact of a Home-Based Walking Intervention on Outcomes of Sleep Quality, Emotional Distress, and Fatigue in Patients Undergoing Treatment for Solid Tumors ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Abstract 

1306faPurpose. Exercise use among patients with cancer has been shown to have many benefits and few notable risks. The purpose of this study was to evaluate the impact of a home-based walking intervention during cancer treatment on sleep quality, emotional distress, and fatigue. 

Methods. A total of 138 patients with prostate (55.6%), breast (32.5%), and other solid tumors (11.9%) were randomized to a home-based walking intervention or usual care. Exercise dose was assessed using a five-item subscale of the Cooper Aerobics Center Longitudinal Study Physical Activity Questionnaire. Primary outcomes of sleep quality, distress, and fatigue were compared between the two study arms. 

Results. The exercise group (n = 68) reported more vigor (p = .03) than control group participants (n = 58). In dose response models, greater participation in aerobic exercise was associated with 11% less fatigue (p < .001), 7.5% more vigor (p = .001), and 3% less emotional distress (p = .03), after controlling for intervention group assignment, age, and baseline exercise and fatigue levels. 

Conclusion. Patients who exercised during cancer treatment experienced less emotional distress than those who were less active. Increasing exercise was also associated with less fatigue and more vigor. Home-based walking is a simple, sustainable strategy that may be helpful in improving a number of symptoms encountered by patients undergoing active treatment for cancer. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Jennifer A. Wenzel, Kathleen A. Griffith, JingJing Shang, Carol B. Thompson, Haley Hedlin, Kerry J. Stewart, Theodore DeWeese, Victoria Mock ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '81490',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13576',
        'uid' => '5392',
        'filename' => 'onc0041313060001.jpg',
        'filepath' => 'sites/default/files/onc0041313060001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '26273',
        'status' => '1',
        'timestamp' => '1366751265',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366751265',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61054',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366751141',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61054',
    'revision_uid' => '1',
    'title' => 'article18_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article180413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13575',
        'uid' => '5392',
        'filename' => 'article18_0413.html',
        'filepath' => 'sites/default/files/article18_0413.html',
        'filemime' => 'text/html',
        'filesize' => '61011',
        'status' => '1',
        'timestamp' => '1366751141',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Factors Associated With Fatigue After Surgery in Women With Early-Stage Invasive Breast Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. Fatigue1255fa is one of the most frequent symptoms in patients with cancer. However, the precise determinants of fatigue are still unknown. This study was conducted to investigate factors correlated with cancer-related fatigue before surgery and just before subsequent adjuvant therapy. 

Methods. Patients completed the Multidimensional Fatigue Inventory (MFI-20), the European Organization for Research and Treatment of Cancer 30-item quality-of-life questionnaire before and after surgery, the Trait Anxiety Inventory and the Life Orientation Test before surgery, and the State Anxiety Inventory before the start of adjuvant therapy. Multiple regression analysis of determinants of change in MFI-20 total score after surgery was conducted. 

Results. A series of 466 eligible patients with stage I-III breast cancer with planned surgery were recruited. An increase in MFI-20 total score after surgery was significantly correlated with higher preoperative fatigue and lower role functioning before surgery; a decrease in role functioning, physical functioning, and cognitive functioning after surgery; an increase in insomnia after surgery; and a higher state anxiety after surgery. Disease stage, lymph node metastases, surgical procedure, and demographic characteristics (e.g., age, marital status, having children, educational level) were not correlated with fatigue in multivariate analysis. 

Conclusion. These results suggest that worsening fatigue after surgery for breast cancer is associated with a decrease in physical functioning and an increase in psychological distress rather than with the cancer characteristics. Therefore, screening measures should be implemented at the time of diagnosis--before starting treatment--to identify psychologically vulnerable patients and to offer them professional support. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Christine Rotonda, Francis Guillemin, Franck Bonnetain, Michel Velten, Thierry Conroy ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '61011',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366751141',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61053',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366750938',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61053',
    'revision_uid' => '1',
    'title' => 'article17_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article170413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13574',
        'uid' => '5392',
        'filename' => 'article17_0413.html',
        'filepath' => 'sites/default/files/article17_0413.html',
        'filemime' => 'text/html',
        'filesize' => '41351',
        'status' => '1',
        'timestamp' => '1366750937',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squamous Cell Head and Neck Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'On November 7, 2011, the U.S. Food and Drug Administration approved cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil for the first-line treatment of patients with recurrent locoregional or metastatic squamous cell head and neck cancer. Approval was based on a randomized study of 442 patients conducted outside the U.S. Cisplatin (100 mg/m2 intravenously) or carboplatin (area under the curve 5 intravenously) on day 1 with 5-fluorouracil (1,000 mg/m2/day continuous intravenous infusion days 1-4) were administered every 3 weeks. Cetuximab, 400 mg/m2 intravenously, was administered initially followed by cetuximab, 250 mg/m2 intravenously weekly. After completion of six planned treatment courses, cetuximab patients without progression continued cetuximab 250 mg/m2 weekly. The study used European Union (EU)-approved cetuximab rather than U.S.-approved cetuximab. U.S.-approved cetuximab provides approximately 28% higher exposure relative to EU-approved cetuximab in a pharmacokinetic comparability study in monkeys. Overall survival, the primary efficacy endpoint, was significantly improved in cetuximab-treated patients (hazard ratio [HR]: 0.80; 95% confidence interval [CI]: 0.64-0.98; p = .034, stratified log-rank test). Median survival times were 10.1 and 7.4 months, respectively. Progression-free survival (PFS) was also significantly improved in patients receiving cetuximab (HR: 0.57; 95% CI: 0.46-0.72; p < .0001). Median PFS times were 5.5 and 3.3 months, respectively. Response rates were 35.6% and 19.5% (odds ratio: 2.33; 95% CI: 1.50-3.60; p = .0001). Adverse reactions (≥25%) from cetuximab plus chemotherapy treatment included nausea, anemia, vomiting, neutropenia, rash, asthenia, diarrhea, and anorexia. Conjunctivitis occurred in 10% of cetuximab patients. Other adverse reactions, sometimes severe, included infusion reactions, hypomagnesemia, hypocalcemia, and hypokalemia.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Martin H. Cohen, Huanyu Chen, Stacy Shord, Chana Fuchs, Kun He, Hong Zhao, Sharon Sickafuse, Patricia Keegan, Richard Pazdur ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '56820',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13573',
        'uid' => '5392',
        'filename' => 'onc0041313040001.jpg',
        'filepath' => 'sites/default/files/onc0041313040001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '15469',
        'status' => '1',
        'timestamp' => '1366750937',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366750938',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61052',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366750432',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61052',
    'revision_uid' => '1',
    'title' => 'article16_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13571',
        'uid' => '5392',
        'filename' => 'article16_0413.html',
        'filepath' => 'sites/default/files/article16_0413.html',
        'filemime' => 'text/html',
        'filesize' => '31324',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'High-Resolution Computed Tomography Findings for Patients With Drug-Induced Pulmonary Toxicity, With Special Reference to Hypersensitivity Pneumonitis-Like Patterns in Gemcitabine-Induced Cases ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Gemcitabine (GEM) is widely used as a chemotherapeutic agent. However, pulmonary toxicity has been rarely observed with GEM use. This article aims to determine the incidence and causes of drug-induced pulmonary toxicity, and to classify the high-resolution computed tomography (HRCT) findings for antitumor therapy-associated pulmonary toxicity based on characteristic patterns and pathological considerations, with a special focus on GEM-associated pulmonary toxicity (GAPT). 

Methods. Medical records of all patients with drug-induced pulmonary toxicity seen at Kyorin University hospital between April 2006 and December 2011 were retrospectively reviewed. The study examined correlations between HRCT and the assessed pathological or clinical findings, with a specific focus on antitumor drugs. 

Results. We identified 66 patients with drug-induced pulmonary toxicity. Among the antitumor drugs, GEM was the primary offending agent (n = 8) for pulmonary toxicity followed by docetaxel and gefitinib. HRCT patterns for the eight GAPT patients included the non-specific interstitial pneumonia (NSIP; n = 5) and the hypersensitivity pneumonitis (HP)-like pattern (n = 3). In contrast, four patients in the study were found to have the HP-like pattern, with three cases associated with GEM and one case associated with imatinib mesylate. The transbronchial lung biopsy or video-assisted thoracic surgery specimens for these patients showed granuloma or organizing tissue with a random distribution that was independent of the respiratory bronchiole. These results appeared to correspond to the HRCT-determined centrilobular nodules. 

Conclusion. GEM was the leading cause of drug-induced pulmonary toxicity in the patients examined in this study. This toxicity appears as NSIP or an HP-like pattern during HRCT examinations. This HP-like pattern may be useful for diagnosing GEM-induced pulmonary toxicity, as well as demonstrating granuloma or organizing tissue during lung pathology examinations.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Masaki Tamura, Takeshi Saraya, Masachika Fujiwara, Sayuki Hiraoka, Takuma Yokoyama, Kinuko Yano, Haruyuki Ishii, Junji Furuse, Tomoyuki Goya, Hajime Takizawa, Hajime Goto ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '153404',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13681',
        'uid' => '5392',
        'filename' => 'article16_na_0413.html',
        'filepath' => 'sites/default/files/article16_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '32383',
        'status' => '1',
        'timestamp' => '1366921335',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13568',
        'uid' => '5392',
        'filename' => 'onc9991112290001.jpg',
        'filepath' => 'sites/default/files/onc9991112290001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34307',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13569',
        'uid' => '5392',
        'filename' => 'onc9991112290002.jpg',
        'filepath' => 'sites/default/files/onc9991112290002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '31199',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13570',
        'uid' => '5392',
        'filename' => 'onc9991112290003.jpg',
        'filepath' => 'sites/default/files/onc9991112290003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '56574',
        'status' => '1',
        'timestamp' => '1366750432',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366750432',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61051',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366750281',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61051',
    'revision_uid' => '1',
    'title' => 'article15_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13566',
        'uid' => '5392',
        'filename' => 'article15_0413.html',
        'filepath' => 'sites/default/files/article15_0413.html',
        'filemime' => 'text/html',
        'filesize' => '50533',
        'status' => '1',
        'timestamp' => '1366750281',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Objective. Treatment with anthracyclines may cause cardiac dysfunction, but the sequence of anthracycline-induced heart lesions has been incompletely characterized. NADPH oxidase, a key mediator of oxidative cardiac damage and remodeling, modulates anthracycline clinical cardiotoxicity. Our aim was to determine which cardiac histological lesions are specifically induced by anthracycline treatment and to investigate the role of NADPH functional genetic polymorphisms in their development. 

Patients and Methods. Using a retrospective case-control design, we evaluated cardiac histological lesions and NADPH genotype (polymorphisms rs1883112, rs4673, and rs13058338) in 97 consecutive decedents with a cancer diagnosis (48 treated with anthracyclines). 

Results. Myocytolysis (60%), patched myocardial necrosis (19%), and myocardial fibrosis (diffuse and patched; 62% and 23%, respectively) were associated with anthracycline treatment. In patients receiving anthracyclines, NADPH oxidase polymorphism rs4673 protected against focal myocardial necrosis (odds ratio [OR], 0.11; 95% confidence interval [CI], 0.20-0.63) whereas rs1883112 was strongly associated with cardiac fibrosis (OR, 5.11; 95% CI, 1.59-16.43), which was present in all homozygotes. 

Conclusion. Anthracyclines induce a cardiac remodeling pattern characterized by interstitial or patched fibrosis. The contribution of the functionally relevant NADPH polymorphisms rs1883112 and rs4673 to anthracycline-related heart lesions provides a plausible explanation for their modulation of cardiotoxicity. If confirmed, these findings may lead to better individualized strategies for early detection and prevention of anthracycline cardiotoxicity. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Almudena Cascales, Francisco Pastor-Quirante, Beatriz Sánchez-Vega, Ginés Luengo-Gil, Javier Corral, Guzmán Ortuño-Pacheco, Vicente Vicente, Francisco Ayala de la Peña ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '131530',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13680',
        'uid' => '5392',
        'filename' => 'article15_na_0413.html',
        'filepath' => 'sites/default/files/article15_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '51599',
        'status' => '1',
        'timestamp' => '1366921311',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13564',
        'uid' => '5392',
        'filename' => 'onc9991112650001.jpg',
        'filepath' => 'sites/default/files/onc9991112650001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '57713',
        'status' => '1',
        'timestamp' => '1366750281',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13565',
        'uid' => '5392',
        'filename' => 'onc9991112650002.jpg',
        'filepath' => 'sites/default/files/onc9991112650002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '23284',
        'status' => '1',
        'timestamp' => '1366750281',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366750281',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61043',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366742183',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61043',
    'revision_uid' => '1',
    'title' => 'article14_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13562',
        'uid' => '5392',
        'filename' => 'article14_0413.html',
        'filepath' => 'sites/default/files/article14_0413.html',
        'filemime' => 'text/html',
        'filesize' => '41615',
        'status' => '1',
        'timestamp' => '1366742183',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901 ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Abstract 

1266faAmrubicin, a third-generation synthetic anthracycline agent, has favorable clinical activity and acceptable toxicity for the treatment of patients with non-small cell lung cancer (NSCLC) and small cell lung cancer. We conducted this study to evaluate the efficacy and safety of amrubicin for advanced NSCLC patients as a third- or fourth-line therapy. Eligible patients had recurrent or refractory advanced NSCLC after second- or third-line therapy. Patients received amrubicin, 35 mg/m2 i.v. on days 1-3 every 3 weeks. The primary endpoint was the disease control rate (DCR). Secondary endpoints were the overall survival (OS) time, progression-free survival (PFS) time, response rate, and toxicity profile. Of the 41 patients enrolled, 26 received amrubicin as a third-line and 15 received it as a fourth-line therapy. The median number of treatment cycles was two (range, 1-9). Objective responses were complete response (n = 0), partial response (n = 4), stable disease (n = 21), progressive disease (n = 15), and not evaluable (n = 1), resulting in a DCR of 61.0% (95% confidence interval, 46.0%-75.9%). The overall response rate was 9.8% (95% confidence interval, 0.6%-18.8%). The median PFS interval was 3.0 months, median OS time was 12.6 months, and 1-year survival rate was 53.7%. Grade 3 or 4 hematological toxicities were neutropenia (68%), anemia (12%), thrombocytopenia (12%), and febrile neutropenia (17%). Nonhematological toxicities were mild and reversible. No treatment-related deaths were observed. Amrubicin showed significant clinical activity with manageable toxicities as a third- or fourth-line therapy for patients with advanced NSCLC. This study provides relevant data for routine practice and future prospective trials evaluating third- or fourth-line treatment strategies for patients with advanced NSCLC. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, Kei Takamura, Eiki Kikuchi, Tomoya Kuda, Shunichi Sugawara, Aya Suzuki, Makoto Maemondo, Yuka Fujita, Ichiro Kinoshita, Akira Inoue, Fumihiro Hommura, Yutaka Katsuura, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura, Hokkaido Lung Cancer Clinical Study Group ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '66767',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13679',
        'uid' => '5392',
        'filename' => 'article14_na_0413.html',
        'filepath' => 'sites/default/files/article14_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '42680',
        'status' => '1',
        'timestamp' => '1366921285',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13560',
        'uid' => '5392',
        'filename' => 'onc9991112660001.jpg',
        'filepath' => 'sites/default/files/onc9991112660001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '11462',
        'status' => '1',
        'timestamp' => '1366742183',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13561',
        'uid' => '5392',
        'filename' => 'onc9991112660002.jpg',
        'filepath' => 'sites/default/files/onc9991112660002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13690',
        'status' => '1',
        'timestamp' => '1366742183',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366742183',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61029',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366731936',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61029',
    'revision_uid' => '1',
    'title' => 'article13_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13558',
        'uid' => '5392',
        'filename' => 'article13_0413.html',
        'filepath' => 'sites/default/files/article13_0413.html',
        'filemime' => 'text/html',
        'filesize' => '60808',
        'status' => '1',
        'timestamp' => '1366731936',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Antiangiogenic Therapies for Advanced Hepatocellular Carcinoma ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Hepatocellular carcinoma (HCC) is a significant cause of death worldwide. HCC is a highly vascular tumor, and proangiogenic cytokines such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor may play crucial roles in this disease. Sorafenib, a multikinase inhibitor that blocks VEGF and PDGF signaling, was the first systemic therapy to demonstrate improved survival in patients with advanced HCC. Several other drugs targeting VEGF are in development. Because of the anticipation of eventual resistance to anti-VEGF therapies, drugs that also target alternative proangiogenic pathways are being investigated. Recent clinical and preclinical data along with ongoing studies are reviewed. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Keeran R. Sampat, Bert O\'Neil ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '95103',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13678',
        'uid' => '5392',
        'filename' => 'article13_na_0413.html',
        'filepath' => 'sites/default/files/article13_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '61867',
        'status' => '1',
        'timestamp' => '1366921240',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13557',
        'uid' => '5392',
        'filename' => 'onc9991112900001.jpg',
        'filepath' => 'sites/default/files/onc9991112900001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34295',
        'status' => '1',
        'timestamp' => '1366731936',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366731936',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61025',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366725546',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61025',
    'revision_uid' => '1',
    'title' => 'article12_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article120413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13556',
        'uid' => '5392',
        'filename' => 'article12_0413.html',
        'filepath' => 'sites/default/files/article12_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '41793',
        'status' => '1',
        'timestamp' => '1366725546',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer Survivors ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. An association between treatment for gynecological cancers and risk of osteoporosis has never been formally evaluated. Women treated for these cancers are now living longer than ever before, and prevention of treatment-induced morbidities is important. We aimed to distinguish, in gynecological cancer survivors, whether cancer therapy has additional detrimental effects on bone health above those attributable to hormone withdrawal. 

Methods. We performed a retrospective cross-sectional analysis of dual energy x-ray absorptiometry (DEXA) scan results from 105 women; 64 had undergone bilateral salpingo-oophorectomy (BSO) followed by chemotherapy or radiotherapy for gynecological malignancies, and 41 age-matched women had undergone BSO for benign etiologies. All were premenopausal prior to surgery. 

Results. The median age at DEXA scan for the cancer group was 42 years, and 66% had received hormonal replacement therapy (HRT) following their cancer treatment. For the benign group, the median age was 40 years, and 87% had received HRT. Thirty-nine percent of cancer survivors had abnormal DEXA scan results compared to 15% of the control group, with the majority demonstrating osteopenia. The mean lumbar spine and femoral neck bone mineral densities (BMDs) were significantly lower in cancer patients. A history of gynecological cancer treatment was associated with significantly lower BMD in a multivariate logistic regression. 

Conclusions. Women treated for gynecological malignancies with surgery and adjuvant chemotherapy have significantly lower BMDs than age-matched women who have undergone oophorectomy for noncancer indications. Prospective evaluation of BMD in gynecological cancer patients is recommended to facilitate interventions that will reduce the risk of subsequent fragility fractures. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Chara Stavraka, Kate Maclaran, Hani Gabra, Roshan Agarwal, Sadaf Ghaem-Maghami, Alexandra Taylor, Waljit S. Dhillo, Nick Panay, Sarah P. Blagden ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '70730',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13555',
        'uid' => '5392',
        'filename' => 'onc9991112800001.jpg',
        'filepath' => 'sites/default/files/onc9991112800001_0.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '28937',
        'status' => '1',
        'timestamp' => '1366725546',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366725546',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61024',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366725509',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61024',
    'revision_uid' => '1',
    'title' => 'article12_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article120413-0',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13554',
        'uid' => '5392',
        'filename' => 'article12_0413.html',
        'filepath' => 'sites/default/files/article12_0413.html',
        'filemime' => 'text/html',
        'filesize' => '41793',
        'status' => '1',
        'timestamp' => '1366725509',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer Survivors ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. An association between treatment for gynecological cancers and risk of osteoporosis has never been formally evaluated. Women treated for these cancers are now living longer than ever before, and prevention of treatment-induced morbidities is important. We aimed to distinguish, in gynecological cancer survivors, whether cancer therapy has additional detrimental effects on bone health above those attributable to hormone withdrawal. 

Methods. We performed a retrospective cross-sectional analysis of dual energy x-ray absorptiometry (DEXA) scan results from 105 women; 64 had undergone bilateral salpingo-oophorectomy (BSO) followed by chemotherapy or radiotherapy for gynecological malignancies, and 41 age-matched women had undergone BSO for benign etiologies. All were premenopausal prior to surgery. 

Results. The median age at DEXA scan for the cancer group was 42 years, and 66% had received hormonal replacement therapy (HRT) following their cancer treatment. For the benign group, the median age was 40 years, and 87% had received HRT. Thirty-nine percent of cancer survivors had abnormal DEXA scan results compared to 15% of the control group, with the majority demonstrating osteopenia. The mean lumbar spine and femoral neck bone mineral densities (BMDs) were significantly lower in cancer patients. A history of gynecological cancer treatment was associated with significantly lower BMD in a multivariate logistic regression. 

Conclusions. Women treated for gynecological malignancies with surgery and adjuvant chemotherapy have significantly lower BMDs than age-matched women who have undergone oophorectomy for noncancer indications. Prospective evaluation of BMD in gynecological cancer patients is recommended to facilitate interventions that will reduce the risk of subsequent fragility fractures. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Chara Stavraka, Kate Maclaran, Hani Gabra, Roshan Agarwal, Sadaf Ghaem-Maghami, Alexandra Taylor, Waljit S. Dhillo, Nick Panay, Sarah P. Blagden ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '89114',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13552',
        'uid' => '5392',
        'filename' => 'onc9991112800001.jpg',
        'filepath' => 'sites/default/files/onc9991112800001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '28937',
        'status' => '1',
        'timestamp' => '1366725509',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13553',
        'uid' => '5392',
        'filename' => 'onc9991112800002.jpg',
        'filepath' => 'sites/default/files/onc9991112800002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '18384',
        'status' => '1',
        'timestamp' => '1366725509',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366725509',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61023',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366725253',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61023',
    'revision_uid' => '1',
    'title' => 'article11_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article110413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13551',
        'uid' => '5392',
        'filename' => 'article11_0413.html',
        'filepath' => 'sites/default/files/article11_0413.html',
        'filemime' => 'text/html',
        'filesize' => '50669',
        'status' => '1',
        'timestamp' => '1366725253',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Adaptive 3D Image-Guided Brachytherapy: A Strong Argument in the Debate on Systematic Radical Hysterectomy for Locally Advanced Cervical Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. To evaluate the outcomes of patients with locally advanced cervical cancer treated with three-dimensional image-guided brachytherapy (IGABT) after concomitant chemoradiation (CCRT). 

Materials and Methods. Data from patients treated with CCRT followed by magnetic resonance imaging-guided or computed tomography-guided pulsed-dose-rate brachytherapy, performed according to the Groupe Européen de Curiethérapie-European Society for Radiotherapy and Oncology guidelines, were reviewed. At first, stage I or II patients systematically underwent radical hysterectomy or were offered a randomized study evaluating hysterectomy. Then, hysterectomy was limited to salvage treatment. 

Results. Of 163 patients identified, 27% had stage IB, 57% had stage II, 12% had stage III, and 3% had stage IVA disease. The mean dose delivered (in 2-Gy dose equivalents) to 90% of the high-risk clinical target volume was 78.1 ± 9.6 Gy, whereas the doses delivered to organs at risk were maintained under the usual thresholds. Sixty-one patients underwent a hysterectomy. Macroscopic residual disease was found in 13 cases. With a median follow-up of 36 months (range, 5-79 months), 45 patients had relapsed. The 3-year overall survival rate was 76%. Local and pelvic control rates were 92% and 86%, respectively. According to the Common Toxicity Criteria 3.0, 7.4% of patients experienced late grade 3 or 4 toxicity. Most of those had undergone postradiation radical surgery (2.9% vs. 14.8; p = .005). 

Conclusion. IGABT combined with CCRT provides excellent locoregional control rates with low treatment-related morbidity, justifying the elimination of hysterectomy in the absence of obvious residual disease. Distant metastasis remains an important first relapse and may warrant more aggressive systemic treatment. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Renaud Mazeron, Jennifer Gilmore, Isabelle Dumas, Jérôme Champoudry, Jennifer Goulart, Ben Vanneste, Anne Tailleur, Philippe Morice, Christine Haie-Meder ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '89728',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13549',
        'uid' => '5392',
        'filename' => 'onc9991112700001.jpg',
        'filepath' => 'sites/default/files/onc9991112700001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '22348',
        'status' => '1',
        'timestamp' => '1366725253',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13550',
        'uid' => '5392',
        'filename' => 'onc9991112700002.jpg',
        'filepath' => 'sites/default/files/onc9991112700002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '16711',
        'status' => '1',
        'timestamp' => '1366725253',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366725253',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61020',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366724697',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61020',
    'revision_uid' => '1',
    'title' => 'article10_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13548',
        'uid' => '5392',
        'filename' => 'article10_0413.html',
        'filepath' => 'sites/default/files/article10_0413.html',
        'filemime' => 'text/html',
        'filesize' => '49108',
        'status' => '1',
        'timestamp' => '1366724697',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity when added to chemotherapy. 

Patients and Methods. We conducted a prospective study of patients aged ≥65 years, which evaluated the association between geriatric assessment (GA) metrics and chemotherapy toxicity. We examined differences in characteristics and outcomes of patients with CRC and NSCLC cancers who received bevacizumab with chemotherapy versus chemotherapy alone. 

Results. From a total of 207 patients, 27 (13%) received bevacizumab plus chemotherapy and 180 (87%) received chemotherapy alone. Groups were similar in sociodemographic and cancer characteristics. There were no baseline differences in GA domains except that patients with heart disease were less likely to receive bevacizumab (4% vs. 26%, p = .01). Seventy-eight percent of patients who had bevacizumab had grade 3-5 toxicity compared to only 57% who received chemotherapy alone (p = .06). Patients receiving bevacizumab were more likely to develop grade 3 hypertension than those who received chemotherapy alone (15% vs. 2%, p < .01). In multivariable analysis, factors associated with grade 3 or more toxicity included: bevacizumab (OR: 2.86, p = .04), CRC (OR: 2.54, p < .01), and baseline anemia (OR: 2.58, p = .03). 

Conclusion. Heart disease was more common in those who did not receive bevacizumab. Older patients who receive bevacizumab with chemotherapy have a higher odds of developing a grade 3-5 toxicity compared with those who receive chemotherapy alone. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Supriya G. Mohile, Molly Hardt, William Tew, Cynthia Owusu, Heidi Klepin, Cary Gross, Ajeet Gajra, Stuart M. Lichtman, Tao Feng, Kayo Togawa, Rupal Ramani, Vani Katheria, Kurt Hansen, Arti Hurria, on Behalf of the Cancer and Aging Research Group ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '67336',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13660',
        'uid' => '5392',
        'filename' => 'onc0041313050001.jpg',
        'filepath' => 'sites/default/files/onc0041313050001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '18228',
        'status' => '1',
        'timestamp' => '1366826707',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366724697',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61019',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366724512',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61019',
    'revision_uid' => '1',
    'title' => 'article9_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article90413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13547',
        'uid' => '5392',
        'filename' => 'article9_0413.html',
        'filepath' => 'sites/default/files/article9_0413.html',
        'filemime' => 'text/html',
        'filesize' => '125808',
        'status' => '1',
        'timestamp' => '1366724512',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare catecholamine-secreting tumors derived from chromaffin cells originating in the neural crest. These tumors represent a significant diagnostic and therapeutic challenge because the diagnosis of malignancy is frequently made in retrospect by the development of metastatic or recurrent disease. Complete surgical resection offers the only potential for cure; however, recurrence can occur even after apparently successful resection of the primary tumor. The prognosis for malignant disease is poor because traditional treatment modalities have been limited. The last decade has witnessed exciting discoveries in the study of PCCs and PGLs; advances in molecular genetics have uncovered hereditary and germline mutations of at least 10 genes that contribute to the development of these tumors, and increasing knowledge of genotype-phenotype interactions has facilitated more accurate determination of malignant potential. Elucidating the molecular mechanisms responsible for malignant transformation in these tumors has opened avenues of investigation into targeted therapeutics that show promising results. There have also been significant advances in functional and radiological imaging and in the surgical approach to adrenalectomy, which remains the mainstay of treatment for PCC. In this review, we discuss the currently available diagnostic and therapeutic options for patients with malignant PCCs and PGLs and detail the molecular rationale and clinical evidence for novel and emerging diagnostic and therapeutic strategies. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Aoife J. Lowery, Siun Walsh, Enda W. McDermott, Ruth S. Prichard',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '171930',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13545',
        'uid' => '5392',
        'filename' => 'onc9991112920001.jpg',
        'filepath' => 'sites/default/files/onc9991112920001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24515',
        'status' => '1',
        'timestamp' => '1366724512',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13546',
        'uid' => '5392',
        'filename' => 'onc9991112920002.jpg',
        'filepath' => 'sites/default/files/onc9991112920002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '21607',
        'status' => '1',
        'timestamp' => '1366724512',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366724512',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61018',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366724356',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61018',
    'revision_uid' => '1',
    'title' => 'article8_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13661',
        'uid' => '5392',
        'filename' => 'article8_0413.html',
        'filepath' => 'sites/default/files/article8_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '23284',
        'status' => '1',
        'timestamp' => '1366826848',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'The Cost of Cancer Care--Balancing Our Duties to Patients Versus Society: Are They Mutually Exclusive? ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The cost of cancer care is a topic at the center of a national discourse on fiscal responsibility and resource allocation. According to the Centers for Medicare and Medicaid Services, national health expenditures as a percentage of the U.S. gross domestic product (GDP) totaled 5% in 1965, but are expected to total 20% of GDP by the middle of this decade [1 ]. Although spending on cancer care comprises only 5% of the overall health care budget [2 ], these costs continue to rise at a pace more rapid than any other area of health care [3 ]. National cancer expenditures are projected to increase from $125 billion in 2010 to $173 billion in 2020 [4 ]. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Pallavi Kumar, Beverly Moy ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '23284',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366724356',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '61017',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366723518',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '61017',
    'revision_uid' => '1',
    'title' => 'article7_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13659',
        'uid' => '5392',
        'filename' => 'article7_0413.html',
        'filepath' => 'sites/default/files/article7_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '54016',
        'status' => '1',
        'timestamp' => '1366826627',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient\'s Experience ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. Cancer patients carry rising burdens of health care-related out-of-pocket expenses, and a growing number of patients are considered "underinsured." Our objective was to describe experiences of insured cancer patients requesting copayment assistance and to describe the impact of health care expenses on well-being and treatment. 

Methods. We conducted baseline and follow-up surveys regarding the impact of health care costs on well-being and treatment among cancer patients who contacted a national copayment assistance foundation along with a comparison sample of patients treated at an academic medical center. 

Results. Among 254 participants, 75% applied for drug copayment assistance. Forty-two percent of participants reported a significant or catastrophic subjective financial burden; 68% cut back on leisure activities, 46% reduced spending on food and clothing, and 46% used savings to defray out-of-pocket expenses. To save money, 20% took less than the prescribed amount of medication, 19% partially filled prescriptions, and 24% avoided filling prescriptions altogether. Copayment assistance applicants were more likely than nonapplicants to employ at least one of these strategies to defray costs (98% vs. 78%). In an adjusted analysis, younger age, larger household size, applying for copayment assistance, and communicating with physicians about costs were associated with greater subjective financial burden. 

Conclusion. Insured patients undergoing cancer treatment and seeking copayment assistance experience considerable subjective financial burden, and they may alter their care to defray out-of-pocket expenses. Health insurance does not eliminate financial distress or health disparities among cancer patients. Future research should investigate coverage thresholds that minimize adverse financial outcomes and identify cancer patients at greatest risk for financial toxicity. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'S. Yousuf Zafar, Jeffrey M. Peppercorn, Deborah Schrag, Donald H. Taylor, Amy M. Goetzinger, Xiaoyin Zhong, Amy P. Abernethy ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '144445',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13542',
        'uid' => '5392',
        'filename' => 'onc9991112770001.jpg',
        'filepath' => 'sites/default/files/onc9991112770001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34745',
        'status' => '1',
        'timestamp' => '1366723518',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13657',
        'uid' => '5392',
        'filename' => 'onc9991112770002.jpg',
        'filepath' => 'sites/default/files/onc9991112770002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '31558',
        'status' => '1',
        'timestamp' => '1366826626',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13658',
        'uid' => '5392',
        'filename' => 'onc9991112770003.jpg',
        'filepath' => 'sites/default/files/onc9991112770003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24126',
        'status' => '1',
        'timestamp' => '1366826626',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366723518',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60968',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366664194',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60968',
    'revision_uid' => '1',
    'title' => 'article6_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13540',
        'uid' => '5392',
        'filename' => 'article6_0413.html',
        'filepath' => 'sites/default/files/article6_0413.html',
        'filemime' => 'text/html',
        'filesize' => '6559',
        'status' => '1',
        'timestamp' => '1366664194',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Sorafenib has proven survival benefits in patients with advanced hepatocellular carcinoma (HCC). The viability of continuing sorafenib at a higher dosage in patients who experienced radiologic disease progression was investigated. 

Methods. Patients who experienced disease progression while on sorafenib 400 mg twice daily were randomized to sorafenib 600 mg twice daily (n = 49) or best supportive care (n = 52). The primary end point was progression-free survival (PFS). Time to progression, overall survival, and safety were also evaluated. 

Results. The study did not meet its primary end point. The difference in PFS between the sorafenib arm (3.91 months) and the best supportive care arm (2.69 months) did not reach statistical significance (p = 0.086). Adverse events were mainly grade 1-2 and similar across both groups. In the sorafenib arm, the most frequent events were diarrhea (80%), weight loss (75%), fatigue (67%), hand-foot-skin reaction (49%), abdominal pain (37%), and stomatitis (26%). 

Conclusions. Escalated-dose sorafenib in patients with advanced HCC who progressed while on sorafenib, failed to provide any clinical benefit. Second-line treatment still remains an open issue to be explored in appropriate clinical trials. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Lorenza Rimassa, Tiziana Pressiani, Corrado Boni, Carlo Carnaghi, Elena Rota Caremoli, Stefano Fagiuoli, Paolo Foa, Stefania Salvagni, Enrico Cortesi, Maria Chiara Tronconi, Nicola Personeni, Silvia Bozzarelli, Maria Chiara Banzi, Silvia Fanello, Fabio Romano Lutman, Laura Giordano, Armando Santoro ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '22319',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13677',
        'uid' => '5392',
        'filename' => 'article6_na_0413.html',
        'filepath' => 'sites/default/files/article6_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '7618',
        'status' => '1',
        'timestamp' => '1366921217',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13539',
        'uid' => '5392',
        'filename' => 'onc0041313380001.jpg',
        'filepath' => 'sites/default/files/onc0041313380001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '15760',
        'status' => '1',
        'timestamp' => '1366664194',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366664194',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60967',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366663755',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60967',
    'revision_uid' => '1',
    'title' => 'article5_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13537',
        'uid' => '5392',
        'filename' => 'article5_0413.html',
        'filepath' => 'sites/default/files/article5_0413.html',
        'filemime' => 'text/html',
        'filesize' => '7520',
        'status' => '1',
        'timestamp' => '1366663755',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Treatments that target the vascular endothelial growth factor (VEGF) pathway have efficacy in colorectal cancer. We evaluated tolerability and efficacy of tivozanib (an oral VEGF receptor-1, -2, -3 inhibitor) plus everolimus (an oral mammalian target of rapamycin inhibitor). 

Methods. The phase Ib study followed a 3 + 3 dose-escalation design with three dose levels. The primary objective in the follow-on phase II study was improvement in 2-month progression-free survival (PFS) from 30% (historical benchmark) to 50% in patients with refractory, metastatic colorectal cancer. 

Results. Dose-limiting toxicities in the phase Ib study were grade 3 fatigue and dehydration. Oral tivozanib (1 mg daily for 3 of 4 weeks) and oral everolimus (10 mg daily continuously) were advanced to a 40-patient phase II study. The most common grade 3-4 adverse events were thrombocytopenia and hypophosphatemia. The 2-month PFS rate was 50%, with 20 of 40 patients having stable disease (SD). Seven (18%) patients were treated for ≥6 months. Median PFS and overall survival (OS) times were 3.0 months (95% confidence interval [CI]: 1.9-3.6 months) and 5.6 months (95% CI: 4.4-10.6 months), respectively. Patients who developed grade 1+ hypertension had increased SD rates (65.2% vs. 29.4%) and longer OS times (10.6 vs. 3.7 months). 

Conclusions. The oral combination of tivozanib and everolimus was well tolerated, with stable disease achieved in 50% of patients with refractory, metastatic colorectal cancer. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Brian M. Wolpin, Kimmie Ng, Andrew X. Zhu, Thomas Abrams, Peter C. Enzinger, Nadine J. McCleary, Deborah Schrag, Eunice L. Kwak, Jill N. Allen, Pankaj Bhargava, Jennifer A. Chan, Wolfram Goessling, Lawrence S. Blaszkowsky, Jeffrey G. Supko, Meaghan Elliot, Kaori Sato, Eileen Regan, Jeffrey A. Meyerhardt, Charles S. Fuchs ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '25229',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13676',
        'uid' => '5392',
        'filename' => 'article5_na_0413.html',
        'filepath' => 'sites/default/files/article5_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '8578',
        'status' => '1',
        'timestamp' => '1366921187',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13536',
        'uid' => '5392',
        'filename' => 'onc0041313230001.jpg',
        'filepath' => 'sites/default/files/onc0041313230001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '17709',
        'status' => '1',
        'timestamp' => '1366663755',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366663755',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60966',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366663589',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60966',
    'revision_uid' => '1',
    'title' => 'article4_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article40413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13535',
        'uid' => '5392',
        'filename' => 'article4_0413.html',
        'filepath' => 'sites/default/files/article4_0413.html',
        'filemime' => 'text/html',
        'filesize' => '45434',
        'status' => '1',
        'timestamp' => '1366663589',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Case Control Study of Women Treated With Chemotherapy for Breast Cancer During Pregnancy as Compared With Nonpregnant Patients With Breast Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. The purpose of this analysis was to compare disease-free survival (DFS), progression-free survival (PFS), and overall survival (OS) between pregnant and nonpregnant patients with breast cancer. 

Methods. From 1989 to 2009, 75 women were treated with chemotherapy during pregnancy. Each pregnant case was matched on age and cancer stage to two nonpregnant patients with breast cancer (controls). Fisher\'s exact test, the Kaplan-Meier method, and Cox proportional hazards regression models were used. 

Results. Median follow-up time for patients who were alive at the end of follow-up (n = 159) was 4.20 years (range: 0.28-19.94 years). DFS at 5 years was 72% (95% confidence interval [CI]: 58.3%-82.1%) for pregnant patients and 57% (95% CI: 46.7%-65.8%) for controls (p = .0115). Five-year PFS was 70% (95% CI: 56.8%-80.3%) for pregnant patients and 59% (95% CI: 49.1%-67.5%) for controls (p = .0252). Five-year OS was 77% (95% CI: 63.9%-86.4%) for pregnant patients and 71% (95% CI: 61.1%-78.3%) for controls (p = .0461). Hazard ratio estimates favored improved survival for pregnant patients in univariate analyses and multivariate analyses, controlling for age, year of diagnosis, stage, and tumor grade. 

Conclusions. For patients who received chemotherapy during pregnancy, survival was comparable to--if not better than--that of nonpregnant women. Pregnant patients with breast cancer should receive appropriate local and systemic therapy for breast cancer. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Jennifer K. Litton, Carla L. Warneke, Karin M. Hahn, Shana L. Palla, Henry M. Kuerer, George H. Perkins, Elizabeth A. Mittendorf, Chad Barnett, Ana M. Gonzalez-Angulo, Gabriel N. Hortobágyi, Richard L. Theriault ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '97752',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13533',
        'uid' => '5392',
        'filename' => 'onc9991112910001.jpg',
        'filepath' => 'sites/default/files/onc9991112910001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '37373',
        'status' => '1',
        'timestamp' => '1366663589',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13534',
        'uid' => '5392',
        'filename' => 'onc9991112910002.jpg',
        'filepath' => 'sites/default/files/onc9991112910002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '14945',
        'status' => '1',
        'timestamp' => '1366663589',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366663589',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60964',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366663200',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60964',
    'revision_uid' => '1',
    'title' => 'article3_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13532',
        'uid' => '5392',
        'filename' => 'article3_0413.html',
        'filepath' => 'sites/default/files/article3_0413.html',
        'filemime' => 'text/html',
        'filesize' => '44244',
        'status' => '1',
        'timestamp' => '1366663192',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Introduction. Previous research has demonstrated that many women with ductal carcinoma in situ (DCIS) overestimate their risk for future breast cancer at the time of diagnosis and soon thereafter. This study aims to evaluate risk perceptions after 5 years. 

Patients and Methods. In a longitudinal cohort study, we mailed long-term follow-up surveys to 315 women who had previously responded to a survey 18 months after they were diagnosed with DCIS, excluding those who had experienced recurrence and those not treated at our institution. We evaluated risk perceptions with items used previously in the cohort. 

Results. One hundred ninety-three women (61%) responded. The median time since diagnosis was 5.9 years. We excluded 12 because of recurrence. Of the 181 remaining, 32% perceived at least a moderate 5-year risk for developing DCIS again, 43% perceived at least a moderate lifetime risk for developing DCIS again, 27% perceived at least a moderate 5-year risk for invasive breast cancer, 38% perceived at least a moderate lifetime risk for invasive breast cancer, and 24% perceived at least a moderate risk for DCIS spreading to other body parts. In a multivariate model, worse financial status and higher perceived risk in the previous survey were the only predictors of at least a moderate perception of risk for DCIS spreading. 

Conclusion. Women with a history of DCIS continue to harbor inaccurate perceptions of their risk for future breast cancer events even 5 years after diagnosis. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Kathryn J. Ruddy, Meghan E. Meyer, Anita Giobbie-Hurder, Karen M. Emmons, Jane C. Weeks, Eric P. Winer, Ann H. Partridge ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '62250',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13531',
        'uid' => '5392',
        'filename' => 'onc9991112790001.jpg',
        'filepath' => 'sites/default/files/onc9991112790001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '18006',
        'status' => '1',
        'timestamp' => '1366663191',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366663200',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60961',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366662196',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60961',
    'revision_uid' => '1',
    'title' => 'article2_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13529',
        'uid' => '5392',
        'filename' => 'article2_0413.html',
        'filepath' => 'sites/default/files/article2_0413.html',
        'filemime' => 'text/html',
        'filesize' => '52407',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. The purpose of the study was to estimate the impact on survival and fracture rates of the use of zoledronic acid versus no use (or delayed use) in the adjuvant treatment of patients with early-stage (stages I-III) breast cancer. 

Materials and Methods. We performed a systematic review and meta-analysis of randomized clinical trials. Trials were located through PubMed, ISI, Cochrane Library, and major cancer scientific meeting searches. All trials that randomized patients with primary breast cancer to undergo adjuvant treatment with zoledronic acid versus nonuse, placebo, or delayed use of zoledronic acid as treatment to individuals who develop osteoporosis were considered eligible. Standard meta-analytic procedures were used to analyze the study outcomes. 

Results. Fifteen studies were considered eligible and were further analyzed. The use of zoledronic acid resulted in a statistically significant better overall survival outcome (five studies, 6,414 patients; hazard ratio [HR], 0.81; 95% confidence interval [CI], 0.70-0.94). No significant differences were found for the disease-free survival outcome (seven studies, 7,541 patients; HR, 0.86; 95% CI, 0.70-1.06) or incidence of bone metastases (seven studies, 7,543 patients; odds ratio [OR], 0.94; 95% CI, 0.64-1.37). Treatment with zoledronic acid led to a significantly lower overall fracture rate (OR, 0.78; 95% CI, 0.63-0.96). Finally, the rate of osteonecrosis of the jaw was 0.52%. 

Conclusion. Zoledronic acid as adjuvant therapy in breast cancer patients appears to not only reduce the fracture risk but also offer a survival benefit over placebo or no treatment. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Antonis Valachis, Nikolaos P. Polyzos, Robert E. Coleman, Michael Gnant, Holger Eidtmann, Adam M. Brufsky, Rebecca Aft, Amye J. Tevaarwerk, Karen Swenson, Pehr Lind, Davide Mauri ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '208994',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13674',
        'uid' => '5392',
        'filename' => 'article2_na_0413.html',
        'filepath' => 'sites/default/files/article2_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '53466',
        'status' => '1',
        'timestamp' => '1366920006',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13525',
        'uid' => '5392',
        'filename' => 'onc9991112540001.jpg',
        'filepath' => 'sites/default/files/onc9991112540001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '29099',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13526',
        'uid' => '5392',
        'filename' => 'onc9991112540002.jpg',
        'filepath' => 'sites/default/files/onc9991112540002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '39597',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13527',
        'uid' => '5392',
        'filename' => 'onc9991112540003.jpg',
        'filepath' => 'sites/default/files/onc9991112540003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '44542',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13528',
        'uid' => '5392',
        'filename' => 'onc9991112540004.jpg',
        'filepath' => 'sites/default/files/onc9991112540004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '43349',
        'status' => '1',
        'timestamp' => '1366662196',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366662196',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60938',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1366645426',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60938',
    'revision_uid' => '1',
    'title' => 'article1_na_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13523',
        'uid' => '5392',
        'filename' => 'article1_0413.html',
        'filepath' => 'sites/default/files/article1_0413.html',
        'filemime' => 'text/html',
        'filesize' => '17874',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Screening for Breast Cancer-Related Lymphedema: The Need for Standardization ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'With an overall survival rate of 90% following treatment for breast cancer, post-treatment management has been increasingly focused on sequelae that negatively affect quality of life. Breast cancer-related lymphedema (BCRL) has long been recognized as a dreaded side effect of treatment; it can result in disfigurement, altered body image, pain, functional impairment, and emotional distress (Fig. 1) [1,2,3 ]. The risk of developing BCRL lasts for a lifetime, and the financial implications and burden of caring for this condition are well documented and significant [4,5 ]. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Jean O\'Toole, Lauren S. Jammallo, Cynthia L. Miller, Melissa N. Skolny, Michelle C. Specht, Alphonse G. Taghian ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '81379',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13673',
        'uid' => '5392',
        'filename' => 'article1_na_0413.html',
        'filepath' => 'sites/default/files/article1_na_0413_0.html',
        'filemime' => 'text/html',
        'filesize' => '18933',
        'status' => '1',
        'timestamp' => '1366919984',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13520',
        'uid' => '5392',
        'filename' => 'onc9991112820001.jpg',
        'filepath' => 'sites/default/files/onc9991112820001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24319',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13521',
        'uid' => '5392',
        'filename' => 'onc9991112820002.jpg',
        'filepath' => 'sites/default/files/onc9991112820002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '29810',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13522',
        'uid' => '5392',
        'filename' => 'onc9991112820003.jpg',
        'filepath' => 'sites/default/files/onc9991112820003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '9376',
        'status' => '1',
        'timestamp' => '1366645426',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1366645426',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60209',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365710539',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60209',
    'revision_uid' => '1',
    'title' => 'sctm_article9_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle90413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13496',
        'uid' => '5392',
        'filename' => 'sctm_article9_0413.html',
        'filepath' => 'sites/default/files/sctm_article9_0413.html',
        'filemime' => 'text/html',
        'filesize' => '51402',
        'status' => '1',
        'timestamp' => '1365710539',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Three Years After Transplants in Human Mandibles, Histological and In-Line Holotomography Revealed That Stem Cells Regenerated a Compact Rather Than a Spongy Bone: Biological and Clinical Implications ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Mesenchymal stem cells deriving from dental pulp differentiate into osteoblasts capable of producing bone. In previous studies, we extensively demonstrated that, when seeded on collagen I scaffolds, these cells can be conveniently used for the repair of human mandible defects. Here, we assess the stability and quality of the regenerated bone and vessel network 3 years after the grafting intervention, with conventional procedures and in-line holotomography, an advanced phase-imaging method using synchrotron radiation that offers improved sensitivity toward low-absorbing structures. We found that the regenerated tissue from the graft sites was composed of a fully compact bone with a higher matrix density than control human alveolar spongy bone from the same patient. Thus, the regenerated bone, being entirely compact, is completely different from normal alveolar bone. Although the bone regenerated at the graft sites is not of the proper type found in the mandible, it does seem to have a positive clinical impact. In fact, it creates steadier mandibles, may well increase implant stability, and, additionally, may improve resistance to mechanical, physical, chemical, and pharmacological agents. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Alessandra Giuliani, Adrian Manescu, Max Langer, Franco Rustichelli, Vincenzo Desiderio, Francesca Paino, Alfredo De Rosa, Luigi Laino, Riccardo d\'Aquino, Virginia Tirino, Gianpaolo Papaccio',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '411586',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13490',
        'uid' => '5392',
        'filename' => 'sct0041301450001.jpg',
        'filepath' => 'sites/default/files/sct0041301450001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '70640',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13491',
        'uid' => '5392',
        'filename' => 'sct0041301450002.jpg',
        'filepath' => 'sites/default/files/sct0041301450002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '93931',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13492',
        'uid' => '5392',
        'filename' => 'sct0041301450003.jpg',
        'filepath' => 'sites/default/files/sct0041301450003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '52360',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13493',
        'uid' => '5392',
        'filename' => 'sct0041301450004.jpg',
        'filepath' => 'sites/default/files/sct0041301450004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '55327',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13494',
        'uid' => '5392',
        'filename' => 'sct0041301450005.jpg',
        'filepath' => 'sites/default/files/sct0041301450005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '56110',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13495',
        'uid' => '5392',
        'filename' => 'sct0041301450006.jpg',
        'filepath' => 'sites/default/files/sct0041301450006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '31816',
        'status' => '1',
        'timestamp' => '1365710538',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365710539',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60207',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365710335',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60207',
    'revision_uid' => '1',
    'title' => 'sctm_article8_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle80413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13489',
        'uid' => '5392',
        'filename' => 'sctm_article8_0413.html',
        'filepath' => 'sites/default/files/sctm_article8_0413.html',
        'filemime' => 'text/html',
        'filesize' => '48830',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Recellularization of Acellular Human Small Intestine Using Bone Marrow Stem Cells ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'We aimed to produce an acellular human tissue scaffold with a view to test the possibility of recellularization with bone marrow stem cells to produce a tissue-engineered small intestine (TESI). Human small-bowel specimens (n = 5) were obtained from cadaveric organ donors and treated sequentially with 6% dimethyl sulfoxide in hypotonic buffer, 1% Triton X-100, and DNase. Each small intestine (SI) piece (6 cm) was recellularized with EPCAM+ and CD133+ allogeneic bone marrow stem cells. Histological and molecular analysis demonstrated that after decellularization, all cellular components and nuclear material were removed. Our analysis also showed that the decellularized human SI tissue retained its histoarchitecture with intact villi and major structural proteins. Protein films of common extracellular matrix constituents (collagen I, laminin, and fibronectin) were found in abundance. Furthermore, several residual angiogenic factors were found in the decellularized SI. Following recellularization, we found viable mucin-positive goblet cells, CK18+ epithelial cells in villi adjacent to a muscularis mucosa with α-actin+ smooth muscle cells, and a high repopulation of blood vessels with CD31+ endothelial cells. Our results show that in the future, such a TESI would be ideal for clinical purposes, because it can be derived from the recipient\'s own immunocompatible bone marrow cells, thus avoiding the use of immunosuppression.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Pradeep B. Patil, Priti B. Chougule, Vijay K. Kumar, Stefan Almström, Henrik Bäckdahl, Debashish Banerjee, Gustaf Herlenius, Michael Olausson, Suchitra Sumitran-Holgersson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '435214',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13484',
        'uid' => '5392',
        'filename' => 'sct0041301420001.jpg',
        'filepath' => 'sites/default/files/sct0041301420001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '87274',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13485',
        'uid' => '5392',
        'filename' => 'sct0041301420002.jpg',
        'filepath' => 'sites/default/files/sct0041301420002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '74244',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13486',
        'uid' => '5392',
        'filename' => 'sct0041301420003.jpg',
        'filepath' => 'sites/default/files/sct0041301420003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '55493',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13487',
        'uid' => '5392',
        'filename' => 'sct0041301420004.jpg',
        'filepath' => 'sites/default/files/sct0041301420004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '85836',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13488',
        'uid' => '5392',
        'filename' => 'sct0041301420005.jpg',
        'filepath' => 'sites/default/files/sct0041301420005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '83537',
        'status' => '1',
        'timestamp' => '1365710335',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365710335',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60205',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365708528',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60205',
    'revision_uid' => '1',
    'title' => 'sctm_article7_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle70413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13483',
        'uid' => '5392',
        'filename' => 'sctm_article7_0413.html',
        'filepath' => 'sites/default/files/sctm_article7_0413.html',
        'filemime' => 'text/html',
        'filesize' => '50557',
        'status' => '1',
        'timestamp' => '1365708528',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Integration and Regression of Implanted Engineered Human Vascular Networks During Deep Wound Healing ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The ability of vascularized constructs to integrate with tissues may depend on the kinetics and stability of vascular structure development. This study assessed the functionality and durability of engineered human vasculatures from endothelial progenitors when implanted in a mouse deep burn-wound model. Human vascular networks, derived from endothelial colony-forming cells in hyaluronic acid hydrogels, were transplanted into third-degree burns. On day 3 following transplantation, macrophages rapidly degraded the hydrogel during a period of inflammation; through the transitions from inflammation to proliferation (days 5-7), the host\'s vasculatures infiltrated the construct, connecting with the human vessels within the wound area. The growth of mouse vessels near the wound area supported further integration with the implanted human vasculatures. During this period, the majority of the vessels (~60%) in the treated wound area were human. Although no increase in the density of human vessels was detected during the proliferative phase, they temporarily increased in size. This growth peaked at day 7, the middle of the proliferation stage, and then decreased by the end of the proliferation stage. As the wound reached the remodeling period during the second week after transplantation, the vasculatures including the transplanted human vessels generally regressed, and few microvessels, wrapped by mouse smooth muscle cells and with a vessel area less than 200 µm2 (including the human ones), remained in the healed wound. Overall, this study offers useful insights for the development of vascularization strategies for wound healing and ischemic conditions, for tissue-engineered constructs, and for tissue regeneration. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Donny Hanjaya-Putra, Yu-I Shen, Abigail Wilson, Karen Fox-Talbot, Sudhir Khetan, Jason A. Burdick, Charles Steenbergen, Sharon Gerecht ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '619349',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13478',
        'uid' => '5392',
        'filename' => 'sct0041301410001.jpg',
        'filepath' => 'sites/default/files/sct0041301410001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '53350',
        'status' => '1',
        'timestamp' => '1365708527',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13479',
        'uid' => '5392',
        'filename' => 'sct0041301410002.jpg',
        'filepath' => 'sites/default/files/sct0041301410002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '80202',
        'status' => '1',
        'timestamp' => '1365708528',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13480',
        'uid' => '5392',
        'filename' => 'sct0041301410003.jpg',
        'filepath' => 'sites/default/files/sct0041301410003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '153410',
        'status' => '1',
        'timestamp' => '1365708528',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13481',
        'uid' => '5392',
        'filename' => 'sct0041301410004.jpg',
        'filepath' => 'sites/default/files/sct0041301410004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '154518',
        'status' => '1',
        'timestamp' => '1365708528',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13482',
        'uid' => '5392',
        'filename' => 'sct0041301410005.jpg',
        'filepath' => 'sites/default/files/sct0041301410005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '127312',
        'status' => '1',
        'timestamp' => '1365708528',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365708528',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60204',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365708388',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60204',
    'revision_uid' => '1',
    'title' => 'sctm_article6_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle60413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13477',
        'uid' => '5392',
        'filename' => 'sctm_article6_0413.html',
        'filepath' => 'sites/default/files/sctm_article6_0413.html',
        'filemime' => 'text/html',
        'filesize' => '104918',
        'status' => '1',
        'timestamp' => '1365708388',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Concise Review: Adult Mesenchymal Stem Cells, Adult Neural Crest Stem Cells, and Therapy of Neurological Pathologies: A State of Play',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Adult stem cells are endowed with in vitro multilineage differentiation abilities and constitute an attractive autologous source of material for cell therapy in neurological disorders. With regard to lately published results, the ability of adult mesenchymal stem cells (MSCs) and neural crest stem cells (NCSCs) to integrate and differentiate into neurons once inside the central nervous system (CNS) is currently questioned. For this review, we collected exhaustive data on MSC/NCSC neural differentiation in vitro. We then analyzed preclinical cell therapy experiments in different models for neurological diseases and concluded that neural differentiation is probably not the leading property of adult MSCs and NCSCs concerning neurological pathology management. A fine analysis of the molecules that are secreted by MSCs and NCSCs would definitely be of significant interest regarding their important contribution to the clinical and pathological recovery after CNS lesions. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Virginie Neirinckx, Cécile Coste, Bernard Rogister, Sabine Wislet-Gendebien ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '104918',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365708388',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60203',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365708082',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60203',
    'revision_uid' => '1',
    'title' => 'sctm_article5_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle50413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13476',
        'uid' => '5392',
        'filename' => 'sctm_article5_0413.html',
        'filepath' => 'sites/default/files/sctm_article5_0413.html',
        'filemime' => 'text/html',
        'filesize' => '45688',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Adoptive transfer of antitumor lymphocytes has gained intense interest in the field of cancer therapeutics over the past two decades. Human natural killer (NK) cells are a promising source of lymphocytes for anticancer immunotherapy. NK cells are part of the innate immune system and exhibit potent antitumor activity without need for human leukocyte antigen matching and without prior antigen exposure. Moreover, the derivation of NK cells from pluripotent stem cells could provide an unlimited source of lymphocytes for off-the-shelf therapy. To date, most studies on hematopoietic cell development from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) have used incompletely defined conditions and been on a limited scale. Here, we have used a two-stage culture system to efficiently produce NK cells from hESCs and iPSCs in the absence of cell sorting and without need for xenogeneic stromal cells. This novel combination of embryoid body formation using defined conditions and membrane-bound interleukin 21-expressing artificial antigen-presenting cells allows production of mature and functional NK cells from several different hESC and iPSC lines. Although different hESC and iPSC lines had varying efficiencies in hematopoietic development, all cell lines tested could produce functional NK cells. These methods can be used to generate enough cytotoxic NK cells to treat a single patient from fewer than 250,000 input hESCs/iPSCs. Additionally, this strategy provides a genetically amenable platform to study normal NK cell development and education in vitro.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'David A. Knorr, Zhenya Ni, David Hermanson, Melinda K. Hexum, Laura Bendzick, Laurence J.N. Cooper, Dean A. Lee, Dan S. Kaufman ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '426366',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13471',
        'uid' => '5392',
        'filename' => 'sct0041301380001.jpg',
        'filepath' => 'sites/default/files/sct0041301380001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '91248',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13472',
        'uid' => '5392',
        'filename' => 'sct0041301380002.jpg',
        'filepath' => 'sites/default/files/sct0041301380002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '78445',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13473',
        'uid' => '5392',
        'filename' => 'sct0041301380003.jpg',
        'filepath' => 'sites/default/files/sct0041301380003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '83379',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13474',
        'uid' => '5392',
        'filename' => 'sct0041301380004.jpg',
        'filepath' => 'sites/default/files/sct0041301380004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '84074',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13475',
        'uid' => '5392',
        'filename' => 'sct0041301380005.jpg',
        'filepath' => 'sites/default/files/sct0041301380005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '43532',
        'status' => '1',
        'timestamp' => '1365708082',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365708082',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60202',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365707826',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60202',
    'revision_uid' => '1',
    'title' => 'sctm_article4_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle40413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13470',
        'uid' => '5392',
        'filename' => 'sctm_article4_0413.html',
        'filepath' => 'sites/default/files/sctm_article4_0413.html',
        'filemime' => 'text/html',
        'filesize' => '59664',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Podocalyxin Is a Glycoprotein Ligand of the Human Pluripotent Stem Cell-Specific Probe rBC2LCN',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'In comprehensive glycome analysis with a high-density lectin microarray, we have previously shown that the recombinant N-terminal domain of the lectin BC2L-C from Burkholderia cenocepacia (rBC2LCN) binds exclusively to undifferentiated human induced pluripotent stem (iPS) cells and embryonic stem (ES) cells but not to differentiated somatic cells. Here we demonstrate that podocalyxin, a heavily glycosylated type 1 transmembrane protein, is a glycoprotein ligand of rBC2LCN on human iPS cells and ES cells. When analyzed by DNA microarray, podocalyxin was found to be highly expressed in both iPS cells and ES cells. Western and lectin blotting revealed that rBC2LCN binds to podocalyxin with a high molecular weight of more than 240 kDa in undifferentiated iPS cells of six different origins and four ES cell lines, but no binding was observed in either differentiated mouse feeder cells or somatic cells. The specific binding of rBC2LCN to podocalyxin prepared from a large set of iPS cells (138 types) and ES cells (15 types) was also confirmed using a high-throughput antibody-overlay lectin microarray. Alkaline digestion greatly reduced the binding of rBC2LCN to podocalyxin, indicating that the major glycan ligands of rBC2LCN are presented on O-glycans. Furthermore, rBC2LCN was found to exhibit significant affinity to a branched O-glycan comprising an H type 3 structure (Ka, 2.5 × 104 M-1) prepared from human 201B7 iPS cells, indicating that H type 3 is a most probable potential pluripotency marker. We conclude that podocalyxin is a glycoprotein ligand of rBC2LCN on human iPS cells and ES cells. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Hiroaki Tateno, Asako Matsushima, Keiko Hiemori, Yasuko Onuma, Yuzuru Ito, Kayo Hasehira, Ken Nishimura, Manami Ohtaka, Satoko Takayasu, Mahito Nakanishi, Yuzuru Ikehara, Mio Nakanishi, Kiyoshi Ohnuma, Techuan Chan, Masashi Toyoda, Hidenori Akutsu, Akihiro Umezawa, Makoto Asashima, Jun Hirabayashi',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '272760',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13464',
        'uid' => '5392',
        'filename' => 'sct0041301440001.jpg',
        'filepath' => 'sites/default/files/sct0041301440001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '58742',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13465',
        'uid' => '5392',
        'filename' => 'sct0041301440002.jpg',
        'filepath' => 'sites/default/files/sct0041301440002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '42923',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13466',
        'uid' => '5392',
        'filename' => 'sct0041301440003.jpg',
        'filepath' => 'sites/default/files/sct0041301440003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '33468',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13467',
        'uid' => '5392',
        'filename' => 'sct0041301440004.jpg',
        'filepath' => 'sites/default/files/sct0041301440004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '16367',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13468',
        'uid' => '5392',
        'filename' => 'sct0041301440005.jpg',
        'filepath' => 'sites/default/files/sct0041301440005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24437',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13469',
        'uid' => '5392',
        'filename' => 'sct0041301440006.jpg',
        'filepath' => 'sites/default/files/sct0041301440006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '37159',
        'status' => '1',
        'timestamp' => '1365707826',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365707826',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60200',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365707551',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60200',
    'revision_uid' => '1',
    'title' => 'sctm_article3_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle30413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13463',
        'uid' => '5392',
        'filename' => 'sctm_article3_0413.html',
        'filepath' => 'sites/default/files/sctm_article3_0413.html',
        'filemime' => 'text/html',
        'filesize' => '51364',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Nonxenogeneic Growth and Retinal Differentiation of Human Induced Pluripotent Stem Cells ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Human induced pluripotent stem cells (hiPSCs) possess tremendous potential for the field of regenerative medicine because of their ability to differentiate into any cell type of the body. Such ability has profound implications for translational medicine, because these cells have been implicated for use in cell replacement, disease modeling, and pharmacological screening. However, the translation of established methods for deriving retinal cell types from hiPSCs has been hindered by the use of xenogeneic products for their growth and differentiation. Thus, the ability to derive retinal cell types in the absence of xenogeneic products would represent a significant advancement. The following studies were therefore undertaken to test the ability of hiPSCs to give rise to retinal cells under nonxenogeneic conditions. hiPSCs were maintained in traditional, feeder-free, or xeno-free culture conditions, and their ability to differentiate to a retinal fate was tested. Upon differentiation under all three conditions, cells acquired advancing features of retinal development, eventually yielding cell types of the mature retina. Reverse transcription-polymerase chain reaction and immunocytochemistry confirmed early trends in gene and protein expression patterns in xeno-free derived hiPSCs similar to those in cells derived in mouse embryonic fibroblasts and in feeder-free conditions. Results from this study demonstrate that hiPSCs can be maintained and directed to differentiate into retinal cell types under nonxenogeneic conditions, similar to cells derived using current xenogeneic methodologies. The demonstration of this capability will facilitate future efforts to develop hiPSC-based therapies for retinal disorders and also help to advance in vitro studies of human retinal development. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Akshayalakshmi Sridhar, Melissa M. Steward, Jason S. Meyer',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '679598',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13457',
        'uid' => '5392',
        'filename' => 'sct0041301430001.jpg',
        'filepath' => 'sites/default/files/sct0041301430001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '114550',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13458',
        'uid' => '5392',
        'filename' => 'sct0041301430002.jpg',
        'filepath' => 'sites/default/files/sct0041301430002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '159975',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13459',
        'uid' => '5392',
        'filename' => 'sct0041301430003.jpg',
        'filepath' => 'sites/default/files/sct0041301430003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '118545',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13460',
        'uid' => '5392',
        'filename' => 'sct0041301430004.jpg',
        'filepath' => 'sites/default/files/sct0041301430004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '96506',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13461',
        'uid' => '5392',
        'filename' => 'sct0041301430005.jpg',
        'filepath' => 'sites/default/files/sct0041301430005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '81143',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13462',
        'uid' => '5392',
        'filename' => 'sct0041301430006.jpg',
        'filepath' => 'sites/default/files/sct0041301430006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '57515',
        'status' => '1',
        'timestamp' => '1365707550',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365707551',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60198',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365707239',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60198',
    'revision_uid' => '1',
    'title' => 'sctm_article2_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle20413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13456',
        'uid' => '5392',
        'filename' => 'sctm_article2_0413.html',
        'filepath' => 'sites/default/files/sctm_article2_0413.html',
        'filemime' => 'text/html',
        'filesize' => '52105',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Adaptation to Robust Monolayer Expansion Produces Human Pluripotent Stem Cells With Improved Viability ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The generation of human pluripotent stem cells (hPSCs) of sufficient quantity and quality remains a major challenge for biomedical application. Here we present an efficient feeder-free, high-density monolayer system in which hPSCs become SSEA-3-high and gradually more viable than their feeder-dependent counterparts without changes attributed to culture adaptation. As a consequence, monolayer hPSCs possess advantages over their counterparts in embryoid body development, teratoma formation, freezing as a single-cell suspension, and colony-forming efficiency. Importantly, this monolayer culture system is reversible, preserving the competence of hPSCs to gradually reacquire features of colony growth, if necessary. Therefore, the monolayer culture system is highly suitable for long-term, large-scale propagation of hPSCs, which is necessary in drug development and pluripotent stem cell-based therapies. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Michaela Kunova, Kamil Matulka, Livia Eiselleova, Anton Salykin, Iva Kubikova, Sergiy Kyrylenko, Ales Hampl, Petr Dvorak ',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '275560',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13451',
        'uid' => '5392',
        'filename' => 'sct0041301370001.jpg',
        'filepath' => 'sites/default/files/sct0041301370001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '71081',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13452',
        'uid' => '5392',
        'filename' => 'sct0041301370002.jpg',
        'filepath' => 'sites/default/files/sct0041301370002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '27394',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13453',
        'uid' => '5392',
        'filename' => 'sct0041301370003.jpg',
        'filepath' => 'sites/default/files/sct0041301370003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '30733',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13454',
        'uid' => '5392',
        'filename' => 'sct0041301370004.jpg',
        'filepath' => 'sites/default/files/sct0041301370004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '25090',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13455',
        'uid' => '5392',
        'filename' => 'sct0041301370005.jpg',
        'filepath' => 'sites/default/files/sct0041301370005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '69157',
        'status' => '1',
        'timestamp' => '1365707239',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365707239',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '60197',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1365707014',
    'changed' => '1367357278',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '60197',
    'revision_uid' => '1',
    'title' => 'sctm_article1_0413',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357278',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle10413',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13450',
        'uid' => '5392',
        'filename' => 'sctm_article1_0413.html',
        'filepath' => 'sites/default/files/sctm_article1_0413.html',
        'filemime' => 'text/html',
        'filesize' => '17690',
        'status' => '1',
        'timestamp' => '1365707014',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Andalusian Initiative for Advanced Therapies: Fostering Synergies ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The Iniciativa Andaluza en Terapias Avanzadas (IATA), which in English translates to the Andalusian Initiative for Advanced Therapies, was established to promote the development of new therapies to improve the population\'s health and to incorporate innovative advanced therapies in the health care and progress of our region. To do this we seek alliances with the academic world, research institutions, health centers, patients\' associations, small and medium enterprises, and the pharmaceutical industry. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Natividad Cuende',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '35922',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13448',
        'uid' => '5392',
        'filename' => 'sct0041301540001.jpg',
        'filepath' => 'sites/default/files/sct0041301540001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '15155',
        'status' => '1',
        'timestamp' => '1365707014',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13449',
        'uid' => '5392',
        'filename' => 'sct0041301540002.jpg',
        'filepath' => 'sites/default/files/sct0041301540002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '3077',
        'status' => '1',
        'timestamp' => '1365707014',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1365707014',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '58181',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1364328886',
    'changed' => '1367361159',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '58181',
    'revision_uid' => '1',
    'title' => 'europers_test_0213',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361159',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/europerstest0213',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13422',
        'uid' => '5392',
        'filename' => 'europers2_0213.html',
        'filepath' => 'sites/default/files/europers2_0213.html',
        'filemime' => 'text/html',
        'filesize' => '21433',
        'status' => '1',
        'timestamp' => '1364328886',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Targeted Therapy in Lung Cancer:  Are We Approaching a New Standard of Care?',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Lung cancer deaths in Europe have risen by 7% since 2009. Predictions for 2013 indicate that there will be 187,000 male deaths from lung cancer in 2013, while the number of deaths for women will approach 83,000. If this trend in females continues, lung cancer will become the single biggest cause of cancer deaths in women by the middle of this decade, overtaking breast cancer by 2015. [1] It is in the context of these worrying cancer mortality figures that European Perspectives launches an Expert Opinion series on Lung Cancer, with recognised international experts outlining the scale of the problem and identifying how we as an oncology community must respond to the challenge. In the first of this series, Professor Mark Lawler, Interlocutor for European Perspectives, interviews Professor Jean-Charles Soria, one of Europe’s leaders in thoracic oncology, who indicates the significant progress that has been achieved utilising targeted therapeutic approaches focused on disrupting the biology of the disease. Future articles in this series will focus on cancer prevention, tobacco control, biomarkers and molecular stratification as key opportunities to improve the dismal prognosis in this increasingly common form of cancer.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Jean-Charles Soria, Mark Lawler',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '21433',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1364328886',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '58035',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1364220364',
    'changed' => '1367361159',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '58035',
    'revision_uid' => '1',
    'title' => 'europers3_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361159',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/europers30313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13395',
        'uid' => '5392',
        'filename' => 'europers3_0313.html',
        'filepath' => 'sites/default/files/europers3_0313.html',
        'filemime' => 'text/html',
        'filesize' => '7430',
        'status' => '1',
        'timestamp' => '1364220364',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Defining the Molecular Landscape for Lung Cancer in Europe',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'A key component in the development of personalised medicine approaches in cancer is the availability of clinically annotated biological material from patients in order to define the genetic context of the disease. This permits precise molecular stratification, allowing innovative therapies to be targeted to the appropriate patient population. In non-small cell lung cancer (NSCLC), it has been recognised that there is a pressing need for cooperation at the European level in order to develop such a virtual biobank. The European Thoracic Oncology Platform (ETOP), a pan-European organisation dedicated to the promotion of research and information exchange in thoracic malignancies [1], initiated a translational project entitled Lungscape [2] to establish a retrospective collection of biopsy samples from over 2,000 NSCLC patients, underpinning a coordinated effort to evaluate current and emerging biomarkers in lung cancer. Lungscape is the first stage in the establishment of a comprehensive translational platform for the identification and harmonisation of enhanced diagnostic and prognostic tools for this common malignancy.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Rolf Stahel',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '48242',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13394',
        'uid' => '5392',
        'filename' => 'onc0031313330001.jpg',
        'filepath' => 'sites/default/files/onc0031313330001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '40812',
        'status' => '1',
        'timestamp' => '1364220364',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1364220364',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '58033',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1364220219',
    'changed' => '1367361159',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '58033',
    'revision_uid' => '1',
    'title' => 'europers2_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361159',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/europers20313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13393',
        'uid' => '5392',
        'filename' => 'europers2_0313.html',
        'filepath' => 'sites/default/files/europers2_0313.html',
        'filemime' => 'text/html',
        'filesize' => '27290',
        'status' => '1',
        'timestamp' => '1364220219',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Reducing Lung Cancer and Other Tobacco-Related Cancers in Europe; Smoking Cessation Is the Key ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Tobacco is the greatest preventable cause of cancer in the world [1]. Estimates suggest that approximately one third of all cancers are caused by tobacco use. While 80%–90% of all lung cancers are attributable to tobacco, it also has a causative role in malignancies of the mouth, larynx, pharynx, nose and sinuses, oesophagus, stomach, liver, pancreas, kidney, bladder, cervix and bowel, as well as one type of ovarian cancer and some types of leukaemia. The situation in Europe is particularly worrying. Over 650,000 premature deaths are caused by smoking every year [2]. Only 15% of the world\'s population live in Europe, but this population shoulders nearly one third of the global burden of tobacco-related diseases. Coupled with the extremely negative effect on the health of the European citizen, there is also an economic penalty, with tobacco-related health effects estimated to have cost the European economy between €98–130 billion in the year 2000 [3].',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Luke Clancy',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '44677',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13392',
        'uid' => '5392',
        'filename' => 'onc0031313340001.jpg',
        'filepath' => 'sites/default/files/onc0031313340001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '17387',
        'status' => '1',
        'timestamp' => '1364220219',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1364220219',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '58030',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1364220014',
    'changed' => '1367361159',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '58030',
    'revision_uid' => '1',
    'title' => 'europers1_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361159',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/europers10313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13391',
        'uid' => '5392',
        'filename' => 'europers1_0313.html',
        'filepath' => 'sites/default/files/europers1_0313.html',
        'filemime' => 'text/html',
        'filesize' => '9363',
        'status' => '1',
        'timestamp' => '1364220014',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Facing Down the Enemy: Be Tough on Tobacco!',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'On 29th March 2004, Ireland became the first country in the world to introduce a comprehensive nationwide smoking ban in the workplace. At the time, it was regarded as a high-risk political strategy, as the Irish Minister of Health faced down vested interest in the tobacco and vintner industries. In the days and months leading up to the introduction of the legislation, many commentators opined that it would not be adhered to, but the intervening 9 years have proven them wrong, as this action became the catalyst for a major global public health initiative, with many countries following Ireland\'s lead, culminating in the recent introduction of a smoking ban in Guangzhou in China.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Thierry Le Chevalier, Mark Lawler',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '9363',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1364220014',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57739',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363976339',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57739',
    'revision_uid' => '1',
    'title' => 'article17_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article170313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13377',
        'uid' => '5392',
        'filename' => 'article17_0313.html',
        'filepath' => 'sites/default/files/article17_0313.html',
        'filemime' => 'text/html',
        'filesize' => '59904',
        'status' => '1',
        'timestamp' => '1363976339',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'One-Year Effect of a Nurse-Led Psychosocial Intervention on Depressive Symptoms in Patients With Head and Neck Cancer: A Randomized Controlled Trial',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Many patients with head and neck cancer (HNC) experience depressive symptoms after treatment. This randomized controlled trial investigated the effects of a psychosocial nurse counseling and after intervention (NUCAI) versus usual care on the depressive and HNC-related physical symptoms of patients with HNC at 1 year after diagnosis.

Methods. A total of 205 patients with HNC were randomly assigned to either intervention (n = 103) or usual care (n = 102), with stratification for gender and tumor stage. The NUCAI, which consisted of six bimonthly 45-minute counseling sessions, was a problem-focused intervention aimed at helping patients to manage the physical, psychological, and social consequences of HNC and its treatment. It was nurse-led and offered in combination with regular medical follow-up visits at the University Medical Center Utrecht, the Netherlands. Depressive symptoms at 1 year after diagnosis were the primary outcome. Analyses were performed on an intention-to-treat basis for the total sample and for a predefined subgroup of patients with raised levels of depressive symptoms (Center for Epidemiologic Studies-Depression score ≥12; n = 91) at baseline using mixed-effect models.

Results. One year after HNC treatment, levels of depressive symptoms were significantly lower in the intervention group than in the control group in the total sample and in the subgroup of patients with raised levels of depressive symptoms.

Conclusion. The NUCAI was feasible and effective in reducing depressive symptoms in patients with HNC 1 year after HNC treatment, and especially in patients with raised levels of depressive symptoms. The results of this study need to be confirmed in future studies before the NUCAI can be used in daily clinical practice.

Implications for Practice: Head and neck cancer patients are prone to physical problems, depressive symptoms, and decreased quality of life. The nurse counselling and after intervention (NUCAI) is a nurse-led psychosocial intervention. The NUCAI has been shown to be effective in decreasing depressive symptoms and tumor-and-treatment-related symptoms at one year after treatment in head and neck cancer patients, and especially in patients with raised levels of depressive symptoms. This nurse-led intervention is less intensive compared with other psychosocial interventions and is easy to combine with regular medical follow up. It is, therefore, promising to implement in daily clinical practice.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Ingeborg C. van der Meulen, Anne M. May, Wynand J.G. Ros, Miriam Oosterom, Gert-Jan Hordijk, Ron Koole, J. Rob J. de Leeuw',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '122214',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13318',
        'uid' => '5392',
        'filename' => 'onc0031313020001.jpg',
        'filepath' => 'sites/default/files/onc0031313020001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '35054',
        'status' => '1',
        'timestamp' => '1363898668',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13319',
        'uid' => '5392',
        'filename' => 'onc0031313020002.jpg',
        'filepath' => 'sites/default/files/onc0031313020002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13501',
        'status' => '1',
        'timestamp' => '1363898669',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13320',
        'uid' => '5392',
        'filename' => 'onc0031313020003.jpg',
        'filepath' => 'sites/default/files/onc0031313020003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13755',
        'status' => '1',
        'timestamp' => '1363898669',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363976339',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57737',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363976198',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57737',
    'revision_uid' => '1',
    'title' => 'article15_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article150313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13375',
        'uid' => '5392',
        'filename' => 'article15_0313.html',
        'filepath' => 'sites/default/files/article15_0313.html',
        'filemime' => 'text/html',
        'filesize' => '45352',
        'status' => '1',
        'timestamp' => '1363976198',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Introduction. For anticancer drug development, it is crucial that patients participate in early-phase clinical trials. The main aim of this study was to gain insight into the motivations and other variables influencing patients in their decision to participate in phase I oncology trials.

Materials and Methods. Over a period of 25 months, all patients who were informed about (specific) phase I trials in our cancer center were retrospectively included in this study. Data on providing informed consent and final phase I enrollment were collected.

Results. In total, 365 patients, with a median age of 59 years and a median World Health Organization performance status score of 1, were evaluated. The majority of patients (71%) were pretreated with systemic therapy, with a median of two lines. After specific study information had been given, 145 patients (40%) declined informed consent, 54% of them mainly because of low expectations regarding treatment benefits and concerns about potential side effects. Patients who had received previous systemic therapy consented more frequently than others. After initial consent, 61 patients (17%) still did not receive study treatment, mostly because of secondary withdrawal of consent or rapid clinical deterioration prior to first dosing.

Discussion. After specific referral to our hospital for participation in early clinical trials, only 44% of all patients who were informed about a specific phase I trial eventually participated. Reasons for both participation and nonparticipation were diverse. Patient participation rates could be improved by forming an experienced and dedicated study team.

Clinical drug development is the basis for the further evolution of the field of medical oncology. The early phases of drug development are especially important for testing new compounds, because in these phases, pharmacokinetic endpoints and pharmacodynamic endpoints (toxicity and efficacy) are studied for the first time in a clinical setting. It is, therefore, essential to encourage patients to participate in early clinical trials, despite the potentially limited benefits for themselves. This can only be done in an adequate way if those patients are understood correctly for their motives and other reasons why they do or do not want to participate. In our opinion, the current inclusion rate is disappointingly low, despite specific referral to those trials. Based on our study results, patient incentives are clarified, which could help to improve the inclusion rate in early clinical trials in the future.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Diane A.J. van der Biessen, Merlijn A. Cranendonk, Gaia Schiavon, Bronno van der Holt, Erik A.C. Wiemer, Ferry A.L.M. Eskens, Jaap Verweij, Maja J.A. de Jonge, Ron H.J. Mathijssen',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '257092',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13307',
        'uid' => '5392',
        'filename' => 'onc9991112960001.jpg',
        'filepath' => 'sites/default/files/onc9991112960001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '122898',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13308',
        'uid' => '5392',
        'filename' => 'onc9991112960002.jpg',
        'filepath' => 'sites/default/files/onc9991112960002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '88842',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363976198',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57736',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363975473',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57736',
    'revision_uid' => '1',
    'title' => 'article14_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13374',
        'uid' => '5392',
        'filename' => 'article14_0313.html',
        'filepath' => 'sites/default/files/article14_0313.html',
        'filemime' => 'text/html',
        'filesize' => '47460',
        'status' => '1',
        'timestamp' => '1363975473',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Vemurafenib has been approved for the treatment of patients with advanced BRAFV600E-mutant melanoma. This report by the Vemurafenib Dermatology Working Group presents the characteristics of dermatologic adverse events (AEs) that occur in vemurafenib-treated patients, including cutaneous squamous cell carcinoma (cuSCC).

Methods. Dermatologic AEs were assessed from three ongoing trials of BRAFV600E mutation-positive advanced melanoma. Histologic central review and genetic characterization were completed for a subset of cuSCC lesions.

Results. A total of 520 patients received vemurafenib. The most commonly reported AEs were dermatologic AEs, occurring in 92%-95% of patients. Rash was the most common AE (64%-75% of patients), and the most common types were rash not otherwise specified, erythema, maculopapular rash, and folliculitis. Rash development did not appear to correlate with tumor response. Photosensitivity occurred in 35%-63% of patients, and palmar-plantar erythrodysesthesia (PPE) occurred in 8%-10% of patients. The severity of rash, photosensitivity, and PPE were mainly grade 1 or 2. In all, 19%-26% of patients developed cuSCC, mostly keratoacanthomas (KAs). The majority of patients with cuSCC continued therapy without dose reduction after resection. Genetic analysis of 29 cuSCC/KA samples demonstrated HRAS mutations in 41%.

Conclusions. Dermatologic AEs associated with vemurafenib treatment in patients with melanoma were generally manageable with supportive care measures. Dose interruptions and/or reductions were required in <10% of patients.

Implications for Practice: Vemurafenib has been approved for the treatment of patients with advanced BRAF-mutant melanoma. Skin toxicity is common with vemurafenib therapy, and the majority of patients are able to tolerate and continue therapy following symptomatic and/or local management (e.g., surgical resection). Clinicians should be aware of these toxicities to better educate and manage their patients.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Mario E. Lacouture, Madeleine Duvic, Axel Hauschild, Victor G. Prieto, Caroline Robert, Dirk Schadendorf, Caroline C. Kim, Christopher J. McCormack, Patricia L. Myskowski, Olivia Spleiss, Kerstin Trunzer, Fei Su, Betty Nelson, Keith B. Nolop, Joseph F. Grippo, Richard J. Lee, Matthew J. Klimek, James L. Troy, Andrew K. Joe',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '259200',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13307',
        'uid' => '5392',
        'filename' => 'onc9991112960001.jpg',
        'filepath' => 'sites/default/files/onc9991112960001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '122898',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13308',
        'uid' => '5392',
        'filename' => 'onc9991112960002.jpg',
        'filepath' => 'sites/default/files/onc9991112960002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '88842',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363975473',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57735',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363975418',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57735',
    'revision_uid' => '1',
    'title' => 'article13_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article130313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13373',
        'uid' => '5392',
        'filename' => 'article13_0313.html',
        'filepath' => 'sites/default/files/article13_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '17242',
        'status' => '1',
        'timestamp' => '1363975418',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Upholding the Principles of Autonomy, Beneficence, and Justice in Phase I Clinical Trials',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'In this issue, Kurzrock and Stewart explore the challenges faced by investigators and study subjects in adhering to protocol mandates in the phase I clinical trial setting [1 ]. The authors highlight the peculiarities of early-phase anticancer agent testing--in particular, the need for intensive monitoring that is required for patient safety and to position the compound for possible regulatory approval requirements in the future. The authors report the outcome of a review of 49 institutional phase I clinical trials activated between 2004 and 2007, which demonstrated an average of 45 mandated events per subject within the first 4 weeks on study. Even more concerning was the average number of 105 events observed in their review of 15 industry-sponsored phase I studies at the same institution. The authors see a direct link between increasingly complex study designs and failure to comply with protocol mandates. Given the current lack of clear regulatory guidance on how to handle protocol deviation that may arise from disparate patient factors and circumstances, fear of unwarranted regulatory sanctions creates the potential for subject coercion to ensure study compliance, which is a real threat to the ethical conduct of human subject research.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Taofeek K. Owonikoko',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '17242',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363975418',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57734',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363975301',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57734',
    'revision_uid' => '1',
    'title' => 'article12_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article120313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13372',
        'uid' => '5392',
        'filename' => 'article12_0313.html',
        'filepath' => 'sites/default/files/article12_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '36326',
        'status' => '1',
        'timestamp' => '1363975301',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Compliance in Early-Phase Cancer Clinical Trials Research',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Regulations and ethical principles require that investigators seek consent and that patients participate in experimental studies only under circumstances that minimize the possibility of undue pressure and/or enticements. In recent years, there has been a rapid rise in the monitoring requirements of early-phase trials accompanied by an increasing emphasis on assuring "investigator" compliance with the protocol. It is actually, however, the patient who must comply with the requirements of the study. If there is divergence from the protocol, investigators may be reported to regulatory bodies or agencies. Whereas the investigative community is expected to be vigilant about ensuring that patients participate in studies voluntarily and that their consent is procured without duress, it is also required to guarantee that complex protocols, which entail multiple procedures, be followed exactly by participants who suffer from the complications of advanced cancer. We explore the issue of compliance in a research environment in which investigators are subject to disciplinary action if they fail to ensure that patients adhere precisely to the intense monitoring mandates of a clinical trial.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Razelle Kurzrock, David J. Stewart',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '36326',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363975301',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57733',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974735',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57733',
    'revision_uid' => '1',
    'title' => 'article10_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article100313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13371',
        'uid' => '5392',
        'filename' => 'article10_0313.html',
        'filepath' => 'sites/default/files/article10_0313.html',
        'filemime' => 'text/html',
        'filesize' => '42973',
        'status' => '1',
        'timestamp' => '1363974734',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Trastuzumab for the Treatment of Salivary Duct Carcinoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Objectives. Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with high mortality and poor response to treatment. A significant fraction of SDCs are HER2 positive. This retrospective review examines HER2 testing in SDC and the outcome of trastuzumab-based therapy in adjuvant and palliative settings.

Methods. A total of 13 patients with SDC and HER2/neu expression by immunohistochemistry of 1-3+ were treated with trastuzumab in adjuvant (n = 8) or palliative (n = 5) setting. Adjuvant therapy consisted of concurrent radiation and chemotherapy with weekly paclitaxel, carboplatin, and trastuzumab (TCH) for 6 weeks followed by TCH for 12 weeks and trastuzumab alone for 1 year. Palliative treatment for metastatic disease consisted of TCH every 3 weeks for 6 cycles followed by trastuzumab for variable time periods with or without second-line chemotherapy for progression. All patients had fluorescence in situ hybridization testing for HER2/neu gene amplification.

Results. The median duration of follow-up was 27 months (range: 8-48 months). In all, 62% of adjuvant patients (5/8) had no evidence of disease more than 2 years from completion of therapy. All patients with metastatic disease (5/5 patients) responded to treatment with TCH. One patient achieved a complete response and remains with no evidence of disease 52 months after initiation of TCH. The median duration of response was 18 months (range: 8-52 months).

Conclusion. HER2/neu positivity and treatment with trastuzumab correlated well with long-term survival and response in our patients. Based on this data, we propose that HER2/neu status be examined routinely in all patients with SDCs and the treatment be directed accordingly.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Sewanti A. Limaye, Marshall R. Posner, Jeffrey F. Krane, Maria Fonfria, Jochen H. Lorch, Deborah A. Dillon, Aditya V. Shreenivas, Roy B. Tishler, Robert I. Haddad',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '68737',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13297',
        'uid' => '5392',
        'filename' => 'onc9991112890001.jpg',
        'filepath' => 'sites/default/files/onc9991112890001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '25764',
        'status' => '1',
        'timestamp' => '1363897245',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974735',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57732',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974614',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57732',
    'revision_uid' => '1',
    'title' => 'article9_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article90313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13370',
        'uid' => '5392',
        'filename' => 'article9_0313.html',
        'filepath' => 'sites/default/files/article9_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '42202',
        'status' => '1',
        'timestamp' => '1363974614',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Induction Chemotherapy for Locoregionally Advanced Head and Neck Cancer: Past, Present, Future?',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The treatment of patients with locoregionally advanced squamous cell cancer of the head and neck is still evolving. Induction chemotherapy (IC) is widely used in this patient population and it is unclear how to best incorporate IC into multimodality treatment. Recently, the results of two randomized clinical trials were presented (the PARADIGM and Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer trials), which showed no demonstrable benefit of IC followed by concurrent chemoradiation over concurrent chemoradiotherapy alone. However, a lower rate of distant metastatic disease was noted, suggesting that patients who are at high risk for metastatic disease may benefit from IC. This review summarizes how IC has evolved over the years, provides an update of recent developments, and discusses how IC may develop in the future.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Glenn J. Hanna, Robert I. Haddad, Jochen H. Lorch',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '42202',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974614',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57731',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974541',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57731',
    'revision_uid' => '1',
    'title' => 'article8_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article80313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13369',
        'uid' => '5392',
        'filename' => 'article8_0313.html',
        'filepath' => 'sites/default/files/article8_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '45027',
        'status' => '1',
        'timestamp' => '1363974540',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. To determine the efficacy and toxicity of weekly neoadjuvant cetuximab combined with irinotecan, cisplatin, and radiation therapy in patients with locally advanced esophageal or gastroesophageal junction cancer.

Methods and Materials. Patients with stage IIA-IVA esophageal or gastroesophageal junction cancer were enrolled in a Simon\'s two-stage phase II study. Patients received weekly cetuximab on weeks 0-8 and irinotecan and cisplatin on weeks 1, 2, 4, and 5, with concurrent radiotherapy (50.4 Gy on weeks 1-6), followed by surgical resection.

Results. In the first stage, 17 patients were enrolled, 16 of whom had adenocarcinoma. Because of a low pathologic complete response (pCR) rate in this cohort, the trial was discontinued for patients with adenocarcinoma but squamous cell carcinoma patients continued to be enrolled; two additional patients were enrolled before the study was closed as a result of poor accrual. Of the 19 patients enrolled, 18 patients proceeded to surgery, and 16 patients underwent an R0 resection. Three patients (16%) had a pCR. The median progression-free survival interval was 10 months, and the median overall survival duration was 31 months. Severe neutropenia occurred in 47% of patients, and severe diarrhea occurred in 47% of patients. One patient died preoperatively from sepsis, and one patient died prior to hospital discharge following surgical resection.

Conclusions. This schedule of cetuximab in combination with irinotecan, cisplatin, and radiation therapy was toxic and did not achieve a sufficient pCR rate in patients with localized esophageal adenocarcinoma to undergo further evaluation.

Implications for Practice:Multimodality therapy, involving chemotherapy, radiotherapy, and surgery, has emerged as a standard treatment for locally advanced esophageal cancer. Prognosis with existing therapy for esophageal cancer remains poor, with a 5-year survival rate of only 20% for locally advanced disease. Targeted therapies, such as EGFR inhibitors, are being evaluated for the treatment of locally advanced esophageal cancer, but remain investigational, with a number of ongoing randomized trials exploring the efficacy of various targeted therapies. This study showed that adding the EGFR inhibitor cetuximab to a preoperative chemoradiation regimen of irinotecan, cisplatin, and radiation therapy did not significantly improve rates of pathologic complete response at the time of surgery, and caused substantial toxicity.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Michael S. Lee, Harvey J. Mamon, Theodore S. Hong, Noah C. Choi, Panagiotis M. Fidias, Eunice L. Kwak, Jeffrey A. Meyerhardt, David P. Ryan, Raphael Bueno, Dean M. Donahue, Michael T. Jaklitsch, Michael Lanuti, David W. Rattner, Charles S. Fuchs, Peter C. Enzinger',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '67588',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13292',
        'uid' => '5392',
        'filename' => 'onc9991112710001.jpg',
        'filepath' => 'sites/default/files/onc9991112710001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '22561',
        'status' => '1',
        'timestamp' => '1363896910',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974541',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57730',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974452',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57730',
    'revision_uid' => '1',
    'title' => 'article7_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article70313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13368',
        'uid' => '5392',
        'filename' => 'article7_0313.html',
        'filepath' => 'sites/default/files/article7_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '17771',
        'status' => '1',
        'timestamp' => '1363974452',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'More Sound Cancer Therapy Biomarker Development With Active Noise Control',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Noise can be hazardous to health or simply irritating [1 ]. Acoustics engineers have developed methods to abate risk in hazardous environments, as well as minimize irritation and create unusual comfort in others. For example, many modern dishwashers come equipped with active noise control devices. These microphone/speaker units detect specific sound waves and generate "antiwaves" of equivalent amplitude, actively cancelling the noise [2 ]. This technology allows someone in your kitchen to clean dishes without having to turn up the television volume so loud as to not hear a pot of water over boiling on the stove. On international airplane flights, attendants may distribute headsets with similar devices to provide a trip free from engine noise.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Michael L. Maitland',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '17771',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974452',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57729',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974369',
    'changed' => '1367361159',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57729',
    'revision_uid' => '1',
    'title' => 'article6_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361159',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13405',
        'uid' => '5392',
        'filename' => 'article6_0313.html',
        'filepath' => 'sites/default/files/article6_0313.html',
        'filemime' => 'text/html',
        'filesize' => '52563',
        'status' => '1',
        'timestamp' => '1364233108',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Hypertension is associated with antivascular endothelial growth factor treatment, but the clinical implications of hypertension are uncertain. To assess the prognostic and predictive value of bevacizumab-related hypertension, a comprehensive analysis of whether hypertension and efficacy outcomes are associated was conducted on seven company-sponsored placebo-controlled phase III studies of bevacizumab.

Methods. Patient-specific data were available from 6,486 patients with metastatic colorectal, breast, non-small cell lung, pancreatic, and renal cell cancers. Primary hypertension endpoint was a blood pressure (BP) increase of >20 mmHg systolic or >10 mmHg diastolic within the first 60 days of treatment. Additional endpoints included other predefined thresholds of change in BP and severity of hypertension graded using the National Cancer Institute\'s Common Terminology Criteria for Adverse Events. To analyze the general prognostic importance of an early BP increase, multivariate Cox regression models were used to assess the correlation between BP changes and progression-free (PFS) and overall survival (OS) outcomes in the control groups. To analyze whether early BP increases could predict for benefit from bevacizumab, similar analyses were conducted in the bevacizumab-treated and control groups.

Results. In six of seven studies, early BP increase was neither predictive of clinical benefit from bevacizumab nor prognostic for the course of the disease. For study AVF2107g, early increased BP was associated with longer PFS and OS times in the bevacizumab group but shorter OS time in the control group.

Conclusions. Early treatment-related BP increases do not predict clinical benefit from bevacizumab based on PFS or OS outcomes. BP increases do not appear to have general prognostic importance for patients with advanced cancer.

Implications for Practice: Treatment-related hypertension has been seen with multiple inhibitors of vascular endothelial growth factor (VEGF), including bevacizumab, when treating colorectal, non-small cell lung, renal cell, and brain cancers. Approximately 10%-20% of patients treated with bevacizumab develop grade 3 hypertension. While a qualitative association between hypertension and anti-VEGF therapy has been described, the clinical implications of this association have not been well studied. Current practice has no guidance on strategies related to maximizing hypertension as a strategy to increase patient benefit. There have been many speculations that patients should have their anticancer treatment adjusted to maximally increase blood pressure and/or that blood pressure should be left untreated. Here, a comprehensive analysis of hypertension and efficacy outcomes in seven large clinical studies involving 6,486 patients was performed to evaluate the prognostic and predictive value of bevacizumab-related hypertension. It was found that early treatment-related blood pressure increases do not predict clinical benefit from bevacizumab based on progression-free and overall survival. Blood pressure increases do not appear to have general prognostic importance in patients with advanced cancer. Blood pressure increase should not be used to individualize anticancer therapy; significant hypertension should not be left untreated.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Herbert I. Hurwitz, Pamela S. Douglas, John P. Middleton, George W. Sledge, David H. Johnson, David A. Reardon, Dafeng Chen, Oliver Rosen',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '52563',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974369',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57728',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974271',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57728',
    'revision_uid' => '1',
    'title' => 'article5_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article50313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13367',
        'uid' => '5392',
        'filename' => 'article5_0313.html',
        'filepath' => 'sites/default/files/article5_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '7381',
        'status' => '1',
        'timestamp' => '1363974271',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Esophageal and gastric cancers often present at an advanced stage. Systemic chemotherapy is the mainstay of treatment, but survival with current regimens remains poor. We evaluated the safety, tolerability, and efficacy of the combination capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.

Methods. Thirty-seven patients with metastatic or unresectable gastric/gastroesophageal junction tumors were enrolled and treated with capecitabine 850 mg/m2 BID on days 1-14, and oxaliplatin 130 mg/m2 with bevacizumab 15 mg/kg on day 1 of a 21-day cycle. The primary endpoint was progression-free survival (PFS). Secondary endpoints included response rate (RR) and overall survival (OS). Neuropilin-1 (NRP1) and -2 (NRP2) mRNA expression was evaluated in archived tumor.

Results. Thirty-five patients were evaluable for efficacy. Median PFS was 7.2 months; median OS was 10.8 months. RR was estimated at 51.4%. The regimen was tolerable with expected drug class-related toxicities. NRP2 mRNA levels significantly correlated with PFS (p = 0.042) and showed a trend toward significance with OS (p = 0.051). Nonsignificant trends for NRP1 were noted for higher expression levels and worse outcome.

Conclusions. Bevacizumab can be given safely with chemotherapy in patients with metastatic esophagogastric adenocarcinomas. The combination of capecitabine, oxaliplatin, plus bevacizumab has activity comparable to other bevacizumab-containing regimens in metastatic gastroesophageal cancer.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Hope E. Uronis, Johanna C. Bendell, Ivy Altomare, Gerard C. Blobe, S. David Hsu, Michael A. Morse, Herbert Pang, S. Yousuf Zafar, Paul Conkling, Justin Favaro, Christy C. Arrowood, Stephanie M. Cushman, Kellen L. Meadows, John C. Brady, Andrew B. Nixon, and Herbert I. Hurwitz',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '34032',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13284',
        'uid' => '5392',
        'filename' => 'onc0031313090001.jpg',
        'filepath' => 'sites/default/files/onc0031313090001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '14351',
        'status' => '1',
        'timestamp' => '1363896107',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13285',
        'uid' => '5392',
        'filename' => 'onc0031313090002.jpg',
        'filepath' => 'sites/default/files/onc0031313090002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '12300',
        'status' => '1',
        'timestamp' => '1363896107',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974271',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57727',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363974156',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57727',
    'revision_uid' => '1',
    'title' => 'article3_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article30313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13366',
        'uid' => '5392',
        'filename' => 'article3_0313.html',
        'filepath' => 'sites/default/files/article3_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '46722',
        'status' => '1',
        'timestamp' => '1363974156',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'ntroduction. We report cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel versus placebo plus trastuzumab plus docetaxel observed in the phase III study CLEOPATRA in patients with HER2-positive first-line metastatic breast cancer (MBC).

Patients and Methods. Left ventricular ejection fraction (LVEF) ≥50% and ECOG performance status of 0 or 1 were required for study entry. During the study, LVEF assessments took place every 9 weeks. Pertuzumab/placebo was given at 840 mg, then 420 mg q3w; trastuzumab was administered at 8 mg/kg, then 6 mg/kg q3w, and docetaxel was initiated at 75 mg/m2 q3w.

Results. The incidence of cardiac adverse events (all grades) was 16.4% in the placebo arm and 14.5% in the pertuzumab arm, with left ventricular systolic dysfunction (LVSD, all grades) being the most frequently reported event (8.3% versus 4.4% in the placebo and pertuzumab arm). Declines in LVEF by ≥10% points from baseline and to <50% were reported in 6.6% and 3.8% of patients in the placebo and pertuzumab arm, respectively. Seventy-two percent (placebo arm) and 86.7% (pertuzumab arm) of those patients recovered to a value ≥50%. The incidence of symptomatic LVSD was low, occurring in 1.8% (n = 7) versus 1.0% (n = 4) of patients in the placebo and pertuzumab arm. In 8/11 patients, the symptomatic LVSD had resolved at data cutoff.

Conclusion. The combination of pertuzumab plus trastuzumab plus docetaxel did not increase the incidence of cardiac adverse events, including LVSD, compared with the control arm in HER2-positive MBC. The majority of cardiac adverse events were reversible.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Sandra M. Swain, Michael S. Ewer, Javier Cortés, Dino Amadori, David Miles, Adam Knott, Emma Clark, Mark C. Benyunes, Graham Ross, José Baselga',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '76911',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13277',
        'uid' => '5392',
        'filename' => 'onc0031313010001.jpg',
        'filepath' => 'sites/default/files/onc0031313010001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '16726',
        'status' => '1',
        'timestamp' => '1363895526',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13278',
        'uid' => '5392',
        'filename' => 'onc0031313010002.jpg',
        'filepath' => 'sites/default/files/onc0031313010002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13463',
        'status' => '1',
        'timestamp' => '1363895526',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363974156',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57726',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363973997',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57726',
    'revision_uid' => '1',
    'title' => 'article1_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article10313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13365',
        'uid' => '5392',
        'filename' => 'article1_0313.html',
        'filepath' => 'sites/default/files/article1_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '18838',
        'status' => '1',
        'timestamp' => '1363973997',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Squamous Cell Carcinomas of the Tongue and Oral Cavity as Secondary Malignancies: What Factors Are Implicated?',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The pegylated liposomal doxorubicin (PLD) was introduced clinically in the 1990s and won FDA approvals for the treatment of Kaposi\'s sarcoma (1995) and ovarian cancer (2000). Its attenuated toxicities compared with "free" doxorubicin led to strategies of long-term maintenance in Kaposi\'s sarcoma (KS) [1,2 ] and, subsequently, was adopted in our trials for recurrent ovarian cancers. In 2007, the report of Andreopoulou et al. summarized our experience in 16 patients, with seven continuing beyond 4 years without progression of disease; none had stopped the drug because of toxicities, although skin manifestations led to gradually extending treatment intervals up to 8 weeks and some dose reductions [3 ].',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Franco Muggia',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '18838',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363973997',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57653',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363898669',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57653',
    'revision_uid' => '1',
    'title' => 'article17_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13355',
        'uid' => '5392',
        'filename' => 'article17_0313.html',
        'filepath' => 'sites/default/files/article17_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '59904',
        'status' => '1',
        'timestamp' => '1363964783',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'One-Year Effect of a Nurse-Led Psychosocial Intervention on Depressive Symptoms in Patients With Head and Neck Cancer: A Randomized Controlled Trial ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Many patients with head and neck cancer (HNC) experience depressive symptoms after treatment. This randomized controlled trial investigated the effects of a psychosocial nurse counseling and after intervention (NUCAI) versus usual care on the depressive and HNC-related physical symptoms of patients with HNC at 1 year after diagnosis. 

Methods. A total of 205 patients with HNC were randomly assigned to either intervention (n = 103) or usual care (n = 102), with stratification for gender and tumor stage. The NUCAI, which consisted of six bimonthly 45-minute counseling sessions, was a problem-focused intervention aimed at helping patients to manage the physical, psychological, and social consequences of HNC and its treatment. It was nurse-led and offered in combination with regular medical follow-up visits at the University Medical Center Utrecht, the Netherlands. Depressive symptoms at 1 year after diagnosis were the primary outcome. Analyses were performed on an intention-to-treat basis for the total sample and for a predefined subgroup of patients with raised levels of depressive symptoms (Center for Epidemiologic Studies-Depression score ≥12; n = 91) at baseline using mixed-effect models. 

Results. One year after HNC treatment, levels of depressive symptoms were significantly lower in the intervention group than in the control group in the total sample and in the subgroup of patients with raised levels of depressive symptoms. 

Conclusion. The NUCAI was feasible and effective in reducing depressive symptoms in patients with HNC 1 year after HNC treatment, and especially in patients with raised levels of depressive symptoms. The results of this study need to be confirmed in future studies before the NUCAI can be used in daily clinical practice.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Ingeborg C. van der Meulen, Anne M. May, Wynand J.G. Ros, Miriam Oosterom, Gert-Jan Hordijk, Ron Koole, J. Rob J. de Leeuw',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '122214',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13687',
        'uid' => '5392',
        'filename' => 'article17_na_0313.html',
        'filepath' => 'sites/default/files/article17_na_0313.html',
        'filemime' => 'text/html',
        'filesize' => '60965',
        'status' => '1',
        'timestamp' => '1366921704',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13318',
        'uid' => '5392',
        'filename' => 'onc0031313020001.jpg',
        'filepath' => 'sites/default/files/onc0031313020001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '35054',
        'status' => '1',
        'timestamp' => '1363898668',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13319',
        'uid' => '5392',
        'filename' => 'onc0031313020002.jpg',
        'filepath' => 'sites/default/files/onc0031313020002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13501',
        'status' => '1',
        'timestamp' => '1363898669',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13320',
        'uid' => '5392',
        'filename' => 'onc0031313020003.jpg',
        'filepath' => 'sites/default/files/onc0031313020003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13755',
        'status' => '1',
        'timestamp' => '1363898669',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363898669',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57651',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363898425',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57651',
    'revision_uid' => '1',
    'title' => 'article16_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13359',
        'uid' => '5392',
        'filename' => 'article16_0313.html',
        'filepath' => 'sites/default/files/article16_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '39027',
        'status' => '1',
        'timestamp' => '1363964921',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Recursive Partitioning Analysis for the Prediction of Stereotactic Radiosurgery Brain Metastases Lesion Control ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. The objective of this investigation was to identify independent pretreatment factors that predict for control of local brain metastases (BM) in a large single-institution series of patients receiving stereotactic radiosurgery (SRS). Recursive partitioning analysis was used to potentially identify a class of patients with durable lesion control characteristics. 

Methods. A retrospective SRS database containing baseline characteristics, treatment details, and follow-up data of newly diagnosed patients with 1-3 BM (on magnetic resonance imaging) treated with linear accelerator-based SRS was created. Three study endpoints were used: time to progression (primary endpoint, individual lesion progression; n = 536), time to first progression (secondary endpoint, first lesion progression on an individual patient basis; n = 380), and overall survival (secondary endpoint; n = 380). Recursive partitioning analysis (RPA) was performed to identify predictors of time to progression. 

Results. Multivariable analysis demonstrated that lesion aspect/phenotype and radiotherapy schedule were independent factors associated with both progression outcomes. Presence of tumor necrosis was found to be associated with a significant hazard of progression (hazard ratio >3), whereas use of the most intense radiotherapy fractionation schedule (21 Gy in one fraction) was associated with significant reductions in progression (hazard ratio <0.3). RPA using SRS dose and lesion aspect/phenotype was created and described three distinct prognostic groups. 

Conclusions. RPA of a large retrospective database of patients receiving SRS confirmed previous observations regarding the importance of SRS dose and lesion aspect/phenotype in lesion control and overall survival. The SRS lesion analysis may help to stratify future clinical trials and better define patient care options and prognosis.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'George Rodrigues, Jaap Zindler, Andrew Warner, Frank Lagerwaard',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '102961',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13315',
        'uid' => '5392',
        'filename' => 'onc9991112640001.jpg',
        'filepath' => 'sites/default/files/onc9991112640001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '25816',
        'status' => '1',
        'timestamp' => '1363898425',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13316',
        'uid' => '5392',
        'filename' => 'onc9991112640002.jpg',
        'filepath' => 'sites/default/files/onc9991112640002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '38118',
        'status' => '1',
        'timestamp' => '1363898425',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363898425',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57649',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363898217',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57649',
    'revision_uid' => '1',
    'title' => 'article15_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13353',
        'uid' => '5392',
        'filename' => 'article15_0313.html',
        'filepath' => 'sites/default/files/article15_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '45352',
        'status' => '1',
        'timestamp' => '1363964726',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Introduction. For anticancer drug development, it is crucial that patients participate in early-phase clinical trials. The main aim of this study was to gain insight into the motivations and other variables influencing patients in their decision to participate in phase I oncology trials. 

Materials and Methods. Over a period of 25 months, all patients who were informed about (specific) phase I trials in our cancer center were retrospectively included in this study. Data on providing informed consent and final phase I enrollment were collected. 

Results. In total, 365 patients, with a median age of 59 years and a median World Health Organization performance status score of 1, were evaluated. The majority of patients (71%) were pretreated with systemic therapy, with a median of two lines. After specific study information had been given, 145 patients (40%) declined informed consent, 54% of them mainly because of low expectations regarding treatment benefits and concerns about potential side effects. Patients who had received previous systemic therapy consented more frequently than others. After initial consent, 61 patients (17%) still did not receive study treatment, mostly because of secondary withdrawal of consent or rapid clinical deterioration prior to first dosing. 

Discussion. After specific referral to our hospital for participation in early clinical trials, only 44% of all patients who were informed about a specific phase I trial eventually participated. Reasons for both participation and nonparticipation were diverse. Patient participation rates could be improved by forming an experienced and dedicated study team. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Diane A.J. van der Biessen, Merlijn A. Cranendonk, Gaia Schiavon, Bronno van der Holt, Erik A.C. Wiemer, Ferry A.L.M. Eskens, Jaap Verweij, Maja J.A. de Jonge, Ron H.J. Mathijssen',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '114733',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13686',
        'uid' => '5392',
        'filename' => 'article15_na_0313.html',
        'filepath' => 'sites/default/files/article15_na_0313.html',
        'filemime' => 'text/html',
        'filesize' => '46411',
        'status' => '1',
        'timestamp' => '1366921686',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13311',
        'uid' => '5392',
        'filename' => 'onc9991112870001.jpg',
        'filepath' => 'sites/default/files/onc9991112870001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '48864',
        'status' => '1',
        'timestamp' => '1363898217',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13312',
        'uid' => '5392',
        'filename' => 'onc9991112870002.jpg',
        'filepath' => 'sites/default/files/onc9991112870002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '20517',
        'status' => '1',
        'timestamp' => '1363898217',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363898217',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57648',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363898017',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57648',
    'revision_uid' => '1',
    'title' => 'article14_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13351',
        'uid' => '5392',
        'filename' => 'article14_0313.html',
        'filepath' => 'sites/default/files/article14_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '47460',
        'status' => '1',
        'timestamp' => '1363964671',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Vemurafenib has been approved for the treatment of patients with advanced BRAFV600E-mutant melanoma. This report by the Vemurafenib Dermatology Working Group presents the characteristics of dermatologic adverse events (AEs) that occur in vemurafenib-treated patients, including cutaneous squamous cell carcinoma (cuSCC). 

Methods. Dermatologic AEs were assessed from three ongoing trials of BRAFV600E mutation-positive advanced melanoma. Histologic central review and genetic characterization were completed for a subset of cuSCC lesions. 

Results. A total of 520 patients received vemurafenib. The most commonly reported AEs were dermatologic AEs, occurring in 92%-95% of patients. Rash was the most common AE (64%-75% of patients), and the most common types were rash not otherwise specified, erythema, maculopapular rash, and folliculitis. Rash development did not appear to correlate with tumor response. Photosensitivity occurred in 35%-63% of patients, and palmar-plantar erythrodysesthesia (PPE) occurred in 8%-10% of patients. The severity of rash, photosensitivity, and PPE were mainly grade 1 or 2. In all, 19%-26% of patients developed cuSCC, mostly keratoacanthomas (KAs). The majority of patients with cuSCC continued therapy without dose reduction after resection. Genetic analysis of 29 cuSCC/KA samples demonstrated HRAS mutations in 41%. 

Conclusions. Dermatologic AEs associated with vemurafenib treatment in patients with melanoma were generally manageable with supportive care measures. Dose interruptions and/or reductions were required in <10% of patients.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Mario E. Lacouture, Madeleine Duvic, Axel Hauschild, Victor G. Prieto, Caroline Robert, Dirk Schadendorf, Caroline C. Kim, Christopher J. McCormack, Patricia L. Myskowski, Olivia Spleiss, Kerstin Trunzer, Fei Su, Betty Nelson, Keith B. Nolop, Joseph F. Grippo, Richard J. Lee, Matthew J. Klimek, James L. Troy, Andrew K. Joe',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '259200',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13685',
        'uid' => '5392',
        'filename' => 'article14_na_0313.html',
        'filepath' => 'sites/default/files/article14_na_0313.html',
        'filemime' => 'text/html',
        'filesize' => '48519',
        'status' => '1',
        'timestamp' => '1366921621',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13307',
        'uid' => '5392',
        'filename' => 'onc9991112960001.jpg',
        'filepath' => 'sites/default/files/onc9991112960001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '122898',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13308',
        'uid' => '5392',
        'filename' => 'onc9991112960002.jpg',
        'filepath' => 'sites/default/files/onc9991112960002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '88842',
        'status' => '1',
        'timestamp' => '1363898017',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363898017',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57647',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363897844',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57647',
    'revision_uid' => '1',
    'title' => 'article13_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13305',
        'uid' => '5392',
        'filename' => 'article13_0313.html',
        'filepath' => 'sites/default/files/article13_0313.html',
        'filemime' => 'text/html',
        'filesize' => '17242',
        'status' => '1',
        'timestamp' => '1363897844',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Upholding the Principles of Autonomy, Beneficence, and Justice in Phase I Clinical Trials',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'In this issue, Kurzrock and Stewart explore the challenges faced by investigators and study subjects in adhering to protocol mandates in the phase I clinical trial setting [1 ]. The authors highlight the peculiarities of early-phase anticancer agent testing--in particular, the need for intensive monitoring that is required for patient safety and to position the compound for possible regulatory approval requirements in the future. The authors report the outcome of a review of 49 institutional phase I clinical trials activated between 2004 and 2007, which demonstrated an average of 45 mandated events per subject within the first 4 weeks on study. Even more concerning was the average number of 105 events observed in their review of 15 industry-sponsored phase I studies at the same institution. The authors see a direct link between increasingly complex study designs and failure to comply with protocol mandates. Given the current lack of clear regulatory guidance on how to handle protocol deviation that may arise from disparate patient factors and circumstances, fear of unwarranted regulatory sanctions creates the potential for subject coercion to ensure study compliance, which is a real threat to the ethical conduct of human subject research.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Taofeek K. Owonikoko',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '17242',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363897844',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57646',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363897525',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57646',
    'revision_uid' => '1',
    'title' => 'article12_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13303',
        'uid' => '5392',
        'filename' => 'article12_0313.html',
        'filepath' => 'sites/default/files/article12_0313.html',
        'filemime' => 'text/html',
        'filesize' => '36326',
        'status' => '1',
        'timestamp' => '1363897525',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Compliance in Early-Phase Cancer Clinical Trials Research',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Regulations and ethical principles require that investigators seek consent and that patients participate in experimental studies only under circumstances that minimize the possibility of undue pressure and/or enticements. In recent years, there has been a rapid rise in the monitoring requirements of early-phase trials accompanied by an increasing emphasis on assuring "investigator" compliance with the protocol. It is actually, however, the patient who must comply with the requirements of the study. If there is divergence from the protocol, investigators may be reported to regulatory bodies or agencies. Whereas the investigative community is expected to be vigilant about ensuring that patients participate in studies voluntarily and that their consent is procured without duress, it is also required to guarantee that complex protocols, which entail multiple procedures, be followed exactly by participants who suffer from the complications of advanced cancer. We explore the issue of compliance in a research environment in which investigators are subject to disciplinary action if they fail to ensure that patients adhere precisely to the intense monitoring mandates of a clinical trial.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Razelle Kurzrock, David J. Stewart',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '36326',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363897525',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57645',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363897374',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57645',
    'revision_uid' => '1',
    'title' => 'article11_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/article110313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13302',
        'uid' => '5392',
        'filename' => 'article11_0313.html',
        'filepath' => 'sites/default/files/article11_0313.html',
        'filemime' => 'text/html',
        'filesize' => '43482',
        'status' => '1',
        'timestamp' => '1363897374',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'CD30+ lymphoproliferative disorders represent a spectrum of diseases with distinct clinical phenotypes ranging from reactive conditions to aggressive systemic anaplastic lymphoma kinase (ALK)- anaplastic large cell lymphoma (ALCL). In January 2011, the U.S. Food and Drug Administration (FDA) announced a possible association between breast implants and ALCL, which was likened to systemic ALCL and treated accordingly. We analyzed existing data to see if implant-associated ALCL (iALCL) may represent a distinct entity, different from aggressive ALCL. We conducted a systematic review of publications regarding ALCL and breast implantation for 1990-2012 and contacted corresponding authors to obtain long-term follow-up where available. We identified 44 unique cases of iALCL, the majority of which were associated with seroma, had an ALK- phenotype (97%), and had a good prognosis, different from the expected 40% 5-year survival rate of patients with ALK- nodal ALCL (one case remitted spontaneously following implant removal; only two deaths have been reported to the FDA or in the scientific literature since 1990). The majority of these patients received cyclophosphamide, doxorubicin, vincristine, and prednisolone with or without radiation, but radiation alone also resulted in complete clinical responses. It appears that iALCL demonstrates a strong association with breast implants, a waxing and waning course, and an overall good prognosis, with morphology, cytokine profile, and biological behavior similar to those of primary cutaneous ALCL. Taken together, these data are suggestive that iALCL may start as a reactive process with the potential to progress and acquire an aggressive phenotype typical of its systemic counterpart. A larger analysis and prospective evaluation and follow-up of iALCL patients are necessary to definitively resolve the issue of the natural course of the disease and best therapeutic approaches for these patients.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Sara K. Story, Michael K. Schowalter, Larisa J. Geskin',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '72339',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13300',
        'uid' => '5392',
        'filename' => 'onc9991112620001.jpg',
        'filepath' => 'sites/default/files/onc9991112620001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13651',
        'status' => '1',
        'timestamp' => '1363897374',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13301',
        'uid' => '5392',
        'filename' => 'onc9991112620002.jpg',
        'filepath' => 'sites/default/files/onc9991112620002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '15206',
        'status' => '1',
        'timestamp' => '1363897374',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363897374',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57644',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363897245',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57644',
    'revision_uid' => '1',
    'title' => 'article10_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13349',
        'uid' => '5392',
        'filename' => 'article10_0313.html',
        'filepath' => 'sites/default/files/article10_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '42973',
        'status' => '1',
        'timestamp' => '1363964583',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Trastuzumab for the Treatment of Salivary Duct Carcinoma',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Objectives. Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with high mortality and poor response to treatment. A significant fraction of SDCs are HER2 positive. This retrospective review examines HER2 testing in SDC and the outcome of trastuzumab-based therapy in adjuvant and palliative settings. 

Methods. A total of 13 patients with SDC and HER2/neu expression by immunohistochemistry of 1-3+ were treated with trastuzumab in adjuvant (n = 8) or palliative (n = 5) setting. Adjuvant therapy consisted of concurrent radiation and chemotherapy with weekly paclitaxel, carboplatin, and trastuzumab (TCH) for 6 weeks followed by TCH for 12 weeks and trastuzumab alone for 1 year. Palliative treatment for metastatic disease consisted of TCH every 3 weeks for 6 cycles followed by trastuzumab for variable time periods with or without second-line chemotherapy for progression. All patients had fluorescence in situ hybridization testing for HER2/neu gene amplification. 

Results. The median duration of follow-up was 27 months (range: 8-48 months). In all, 62% of adjuvant patients (5/8) had no evidence of disease more than 2 years from completion of therapy. All patients with metastatic disease (5/5 patients) responded to treatment with TCH. One patient achieved a complete response and remains with no evidence of disease 52 months after initiation of TCH. The median duration of response was 18 months (range: 8-52 months). 

Conclusion. HER2/neu positivity and treatment with trastuzumab correlated well with long-term survival and response in our patients. Based on this data, we propose that HER2/neu status be examined routinely in all patients with SDCs and the treatment be directed accordingly.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Sewanti A. Limaye, Marshall R. Posner, Jeffrey F. Krane, Maria Fonfria, Jochen H. Lorch, Deborah A. Dillon, Aditya V. Shreenivas, Roy B. Tishler, Robert I. Haddad',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '68737',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13297',
        'uid' => '5392',
        'filename' => 'onc9991112890001.jpg',
        'filepath' => 'sites/default/files/onc9991112890001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '25764',
        'status' => '1',
        'timestamp' => '1363897245',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363897245',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57643',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363897086',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57643',
    'revision_uid' => '1',
    'title' => 'article9_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13295',
        'uid' => '5392',
        'filename' => 'article9_0313.html',
        'filepath' => 'sites/default/files/article9_0313.html',
        'filemime' => 'text/html',
        'filesize' => '42202',
        'status' => '1',
        'timestamp' => '1363897086',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Induction Chemotherapy for Locoregionally Advanced Head and Neck Cancer: Past, Present, Future?',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The treatment of patients with locoregionally advanced squamous cell cancer of the head and neck is still evolving. Induction chemotherapy (IC) is widely used in this patient population and it is unclear how to best incorporate IC into multimodality treatment. Recently, the results of two randomized clinical trials were presented (the PARADIGM and Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer trials), which showed no demonstrable benefit of IC followed by concurrent chemoradiation over concurrent chemoradiotherapy alone. However, a lower rate of distant metastatic disease was noted, suggesting that patients who are at high risk for metastatic disease may benefit from IC. This review summarizes how IC has evolved over the years, provides an update of recent developments, and discusses how IC may develop in the future.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Glenn J. Hanna, Robert I. Haddad, Jochen H. Lorch',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '42202',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363897086',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57642',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363896910',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57642',
    'revision_uid' => '1',
    'title' => 'article8_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13347',
        'uid' => '5392',
        'filename' => 'article8_0313.html',
        'filepath' => 'sites/default/files/article8_0313.html',
        'filemime' => 'text/html',
        'filesize' => '45027',
        'status' => '1',
        'timestamp' => '1363964540',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Preoperative Cetuximab, Irinotecan, Cisplatin, and Radiation Therapy for Patients With Locally Advanced Esophageal Cancer ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Purpose. To determine the efficacy and toxicity of weekly neoadjuvant cetuximab combined with irinotecan, cisplatin, and radiation therapy in patients with locally advanced esophageal or gastroesophageal junction cancer. 

Methods and Materials. Patients with stage IIA-IVA esophageal or gastroesophageal junction cancer were enrolled in a Simon\'s two-stage phase II study. Patients received weekly cetuximab on weeks 0-8 and irinotecan and cisplatin on weeks 1, 2, 4, and 5, with concurrent radiotherapy (50.4 Gy on weeks 1-6), followed by surgical resection. 

Results. In the first stage, 17 patients were enrolled, 16 of whom had adenocarcinoma. Because of a low pathologic complete response (pCR) rate in this cohort, the trial was discontinued for patients with adenocarcinoma but squamous cell carcinoma patients continued to be enrolled; two additional patients were enrolled before the study was closed as a result of poor accrual. Of the 19 patients enrolled, 18 patients proceeded to surgery, and 16 patients underwent an R0 resection. Three patients (16%) had a pCR. The median progression-free survival interval was 10 months, and the median overall survival duration was 31 months. Severe neutropenia occurred in 47% of patients, and severe diarrhea occurred in 47% of patients. One patient died preoperatively from sepsis, and one patient died prior to hospital discharge following surgical resection. 

Conclusions. This schedule of cetuximab in combination with irinotecan, cisplatin, and radiation therapy was toxic and did not achieve a sufficient pCR rate in patients with localized esophageal adenocarcinoma to undergo further evaluation.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Michael S. Lee, Harvey J. Mamon, Theodore S. Hong, Noah C. Choi, Panagiotis M. Fidias, Eunice L. Kwak, Jeffrey A. Meyerhardt, David P. Ryan, Raphael Bueno, Dean M. Donahue, Michael T. Jaklitsch, Michael Lanuti, David W. Rattner, Charles S. Fuchs, Peter C. Enzinger',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '67588',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13684',
        'uid' => '5392',
        'filename' => 'article8_na_0313.html',
        'filepath' => 'sites/default/files/article8_na_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '46085',
        'status' => '1',
        'timestamp' => '1366921602',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13292',
        'uid' => '5392',
        'filename' => 'onc9991112710001.jpg',
        'filepath' => 'sites/default/files/onc9991112710001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '22561',
        'status' => '1',
        'timestamp' => '1363896910',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363896910',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57641',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363896743',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57641',
    'revision_uid' => '1',
    'title' => 'article7_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13290',
        'uid' => '5392',
        'filename' => 'article7_0313.html',
        'filepath' => 'sites/default/files/article7_0313.html',
        'filemime' => 'text/html',
        'filesize' => '17771',
        'status' => '1',
        'timestamp' => '1363896743',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'More Sound Cancer Therapy Biomarker Development With Active Noise Control ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Noise can be hazardous to health or simply irritating [1 ]. Acoustics engineers have developed methods to abate risk in hazardous environments, as well as minimize irritation and create unusual comfort in others. For example, many modern dishwashers come equipped with active noise control devices. These microphone/speaker units detect specific sound waves and generate "antiwaves" of equivalent amplitude, actively cancelling the noise [2 ]. This technology allows someone in your kitchen to clean dishes without having to turn up the television volume so loud as to not hear a pot of water over boiling on the stove. On international airplane flights, attendants may distribute headsets with similar devices to provide a trip free from engine noise. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Michael L. Maitland',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '17771',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363896743',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57640',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363896400',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57640',
    'revision_uid' => '1',
    'title' => 'article6_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13343',
        'uid' => '5392',
        'filename' => 'article6_0313.html',
        'filepath' => 'sites/default/files/article6_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '52563',
        'status' => '1',
        'timestamp' => '1363964463',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Hypertension is associated with antivascular endothelial growth factor treatment, but the clinical implications of hypertension are uncertain. To assess the prognostic and predictive value of bevacizumab-related hypertension, a comprehensive analysis of whether hypertension and efficacy outcomes are associated was conducted on seven company-sponsored placebo-controlled phase III studies of bevacizumab. 

Methods. Patient-specific data were available from 6,486 patients with metastatic colorectal, breast, non-small cell lung, pancreatic, and renal cell cancers. Primary hypertension endpoint was a blood pressure (BP) increase of >20 mmHg systolic or >10 mmHg diastolic within the first 60 days of treatment. Additional endpoints included other predefined thresholds of change in BP and severity of hypertension graded using the National Cancer Institute\'s Common Terminology Criteria for Adverse Events. To analyze the general prognostic importance of an early BP increase, multivariate Cox regression models were used to assess the correlation between BP changes and progression-free (PFS) and overall survival (OS) outcomes in the control groups. To analyze whether early BP increases could predict for benefit from bevacizumab, similar analyses were conducted in the bevacizumab-treated and control groups. 

Results. In six of seven studies, early BP increase was neither predictive of clinical benefit from bevacizumab nor prognostic for the course of the disease. For study AVF2107g, early increased BP was associated with longer PFS and OS times in the bevacizumab group but shorter OS time in the control group. 

Conclusions. Early treatment-related BP increases do not predict clinical benefit from bevacizumab based on PFS or OS outcomes. BP increases do not appear to have general prognostic importance for patients with advanced cancer.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Herbert I. Hurwitz, Pamela S. Douglas, John P. Middleton, George W. Sledge, David H. Johnson, David A. Reardon, Dafeng Chen, Oliver Rosen',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '52563',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13683',
        'uid' => '5392',
        'filename' => 'article6_na_0313.html',
        'filepath' => 'sites/default/files/article6_na_0313.html',
        'filemime' => 'text/html',
        'filesize' => '53621',
        'status' => '1',
        'timestamp' => '1366921509',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363896400',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57638',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363896107',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57638',
    'revision_uid' => '1',
    'title' => 'article5_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13286',
        'uid' => '5392',
        'filename' => 'article5_0313.html',
        'filepath' => 'sites/default/files/article5_0313.html',
        'filemime' => 'text/html',
        'filesize' => '7381',
        'status' => '1',
        'timestamp' => '1363896107',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Esophageal and gastric cancers often present at an advanced stage. Systemic chemotherapy is the mainstay of treatment, but survival with current regimens remains poor. We evaluated the safety, tolerability, and efficacy of the combination capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas. 

Methods. Thirty-seven patients with metastatic or unresectable gastric/gastroesophageal junction tumors were enrolled and treated with capecitabine 850 mg/m2 BID on days 1-14, and oxaliplatin 130 mg/m2 with bevacizumab 15 mg/kg on day 1 of a 21-day cycle. The primary endpoint was progression-free survival (PFS). Secondary endpoints included response rate (RR) and overall survival (OS). Neuropilin-1 (NRP1) and -2 (NRP2) mRNA expression was evaluated in archived tumor. 

Results. Thirty-five patients were evaluable for efficacy. Median PFS was 7.2 months; median OS was 10.8 months. RR was estimated at 51.4%. The regimen was tolerable with expected drug class-related toxicities. NRP2 mRNA levels significantly correlated with PFS (p = 0.042) and showed a trend toward significance with OS (p = 0.051). Nonsignificant trends for NRP1 were noted for higher expression levels and worse outcome. 

Conclusions. Bevacizumab can be given safely with chemotherapy in patients with metastatic esophagogastric adenocarcinomas. The combination of capecitabine, oxaliplatin, plus bevacizumab has activity comparable to other bevacizumab-containing regimens in metastatic gastroesophageal cancer. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Hope E. Uronis, Johanna C. Bendell, Ivy Altomare, Gerard C. Blobe, S. David Hsu, Michael A. Morse, Herbert Pang, S. Yousuf Zafar, Paul Conkling, Justin Favaro, Christy C. Arrowood, Stephanie M. Cushman, Kellen L. Meadows, John C. Brady, Andrew B. Nixon, and Herbert I. Hurwitz',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '34032',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13664',
        'uid' => '5392',
        'filename' => 'article5_na_0313.html',
        'filepath' => 'sites/default/files/article5_na_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '8441',
        'status' => '1',
        'timestamp' => '1366903397',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13284',
        'uid' => '5392',
        'filename' => 'onc0031313090001.jpg',
        'filepath' => 'sites/default/files/onc0031313090001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '14351',
        'status' => '1',
        'timestamp' => '1363896107',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13285',
        'uid' => '5392',
        'filename' => 'onc0031313090002.jpg',
        'filepath' => 'sites/default/files/onc0031313090002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '12300',
        'status' => '1',
        'timestamp' => '1363896107',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363896107',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57637',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363895809',
    'changed' => '1367361160',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57637',
    'revision_uid' => '1',
    'title' => 'article4_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361160',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13358',
        'uid' => '5392',
        'filename' => 'article4_0313.html',
        'filepath' => 'sites/default/files/article4_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '35704',
        'status' => '1',
        'timestamp' => '1363964872',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Background. Radiation recall is an acute inflammatory reaction within a previously irradiated field triggered by chemotherapy administration. We observed a series of patients with unexpectedly severe reactions that included radiation recall and delayed healing when patients received the microtubule stabilizer ixabepilone (Ixempra; Bristol-Myers Squibb, Princeton, NJ) after radiation. We therefore decided to evaluate our experience in patients receiving ixabepilone following radiotherapy. 

Methods. We performed a retrospective chart review of all patients treated with curative intent in the Department of Radiation Oncology at the MD Anderson Cancer Center from 2008-2011 who received any ixabepilone after completion of external-beam radiation therapy. These patients received adjuvant ixabepilone on one of two protocols, either for locally advanced breast cancer or for metastatic breast cancer. In total, 19 patients were identified and their charts were subsequently reviewed for evidence of ixabepilone-related toxicity. 

Results. Of the 19 patients identified who received ixabepilone following radiation therapy, three (15.8%) had unexpectedly serious reactions in the months following radiation therapy. Complications included delayed wound closure and drain placement into the seroma, intense erythema, and delayed wound closure and grade 4 chest wall necrosis requiring latissimus flap and skin grafting. The average number of days between the end of radiation therapy and documentation of reaction was 99. 

Conclusions. Ixabepilone chemotherapy may induce radiation recall and delayed wound healing when used shortly after the completion of external-beam radiotherapy. Significant clinical interactions have not been previously reported and merit further evaluation.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Vinita Takiar, Eric A. Strom, Donald P. Baumann, Funda Meric-Bernstam, Ricardo H. Alvarez, Ana M. Gonzalez-Angulo',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '101918',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13281',
        'uid' => '5392',
        'filename' => 'onc9991112610001.jpg',
        'filepath' => 'sites/default/files/onc9991112610001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '23922',
        'status' => '1',
        'timestamp' => '1363895809',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13282',
        'uid' => '5392',
        'filename' => 'onc9991112610002.jpg',
        'filepath' => 'sites/default/files/onc9991112610002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '42292',
        'status' => '1',
        'timestamp' => '1363895809',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363895809',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57633',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363895526',
    'changed' => '1367357277',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57633',
    'revision_uid' => '1',
    'title' => 'article3_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357277',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13279',
        'uid' => '5392',
        'filename' => 'article3_0313.html',
        'filepath' => 'sites/default/files/article3_0313.html',
        'filemime' => 'text/html',
        'filesize' => '46722',
        'status' => '1',
        'timestamp' => '1363895526',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2-Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double-Blind, Placebo-Controlled Phase III Study ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Introduction. We report cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel versus placebo plus trastuzumab plus docetaxel observed in the phase III study CLEOPATRA in patients with HER2-positive first-line metastatic breast cancer (MBC). 

Patients and Methods. Left ventricular ejection fraction (LVEF) ≥50% and ECOG performance status of 0 or 1 were required for study entry. During the study, LVEF assessments took place every 9 weeks. Pertuzumab/placebo was given at 840 mg, then 420 mg q3w; trastuzumab was administered at 8 mg/kg, then 6 mg/kg q3w, and docetaxel was initiated at 75 mg/m2 q3w. 

Results. The incidence of cardiac adverse events (all grades) was 16.4% in the placebo arm and 14.5% in the pertuzumab arm, with left ventricular systolic dysfunction (LVSD, all grades) being the most frequently reported event (8.3% versus 4.4% in the placebo and pertuzumab arm). Declines in LVEF by ≥10% points from baseline and to <50% were reported in 6.6% and 3.8% of patients in the placebo and pertuzumab arm, respectively. Seventy-two percent (placebo arm) and 86.7% (pertuzumab arm) of those patients recovered to a value ≥50%. The incidence of symptomatic LVSD was low, occurring in 1.8% (n = 7) versus 1.0% (n = 4) of patients in the placebo and pertuzumab arm. In 8/11 patients, the symptomatic LVSD had resolved at data cutoff. 

Conclusion. The combination of pertuzumab plus trastuzumab plus docetaxel did not increase the incidence of cardiac adverse events, including LVSD, compared with the control arm in HER2-positive MBC. The majority of cardiac adverse events were reversible.

Implications for Practice: CLEOPATRA was the first phase III trial in which the combination of pertuzumab with trastuzumab and docetaxel was studied in patients with HER2-positive metastatic breast cancer in the first line. As therapy with trastuzumab, especially in combination with anthracyclines, has been associated with cardiac dysfunction, it was important to investigate the cardiac tolerability of the study combination of two HER2-targeted antibodies, trastuzumab and pertuzumab, with docetaxel. Our analyses showed that the combination of pertuzumab, trastuzumab, and docetaxel was not associated with an increase in cardiac dysfunction, especially LVSD, compared with placebo, trastuzumab and docetaxel. Cardiac adverse events were largely reversible and clinically manageable. Despite our encouraging findings, we recommend the regular cardiac monitoring of patients while long-term safety data with pertuzumab-trastuzumab-based treatment are still being accrued in clinical practice. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Sandra M. Swain, Michael S. Ewer, Javier Cortés, Dino Amadori, David Miles, Adam Knott, Emma Clark, Mark C. Benyunes, Graham Ross, José Baselga',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '76911',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13277',
        'uid' => '5392',
        'filename' => 'onc0031313010001.jpg',
        'filepath' => 'sites/default/files/onc0031313010001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '16726',
        'status' => '1',
        'timestamp' => '1363895526',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13278',
        'uid' => '5392',
        'filename' => 'onc0031313010002.jpg',
        'filepath' => 'sites/default/files/onc0031313010002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '13463',
        'status' => '1',
        'timestamp' => '1363895526',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363895526',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57632',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363895308',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57632',
    'revision_uid' => '1',
    'title' => 'article2_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13357',
        'uid' => '5392',
        'filename' => 'article2_0313.html',
        'filepath' => 'sites/default/files/article2_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '60750',
        'status' => '1',
        'timestamp' => '1363964826',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'A Review of Breast Cancer Care and Outcomes in Latin America ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'This review presents an overview of breast cancer care, burden, and outcomes in Latin America, as well as the challenges and opportunities for improvement. Information was gleaned through a review of the literature, public databases, and conference presentations, in addition to a survey of clinical experts and patient organizations from the region. Breast cancer annual incidence (114,900 cases) and mortality (37,000 deaths) are the highest of all women\'s cancers in Latin America, and they are increasing. Twice as many breast cancer deaths are expected by 2030. In Peru, Mexico, Colombia, and Brazil, diagnosis and death at younger ages deprives society of numerous productive years, as does high disease occurrence in Argentina and Uruguay. Approximately 30%-40% of diagnoses are metastatic disease. High mortality-to-incidence ratios (MIRs) in Latin America indicate poor survival, partly because of the late stage at diagnosis and poorer access to treatment. Between 2002 and 2008, MIRs decreased in all countries, albeit unevenly. Costa Rica\'s change in MIR outpaced incidence growth, indicating impressive progress in breast cancer survival. The situation is similar, although to a lesser extent, in Colombia and Ecuador. The marginal drops of MIRs in Brazil and Mexico mainly reflect incidence growth rather than progress in outcomes. Panama\'s MIR is still high. Epidemiological data are scattered and of varying quality in Latin America. However, one could ascertain that the burden of breast cancer in the region is considerable and growing due to demographic changes, particularly the aging population, and socioeconomic development. Early diagnosis and population-wide access to evidence-based treatment remain unresolved problems, despite progress achieved by some countries.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Nahila Justo, Nils Wilking, Bengt Jönsson, Silvana Luciani, Eduardo Cazap',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '112096',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13273',
        'uid' => '5392',
        'filename' => 'onc9991112720001.jpg',
        'filepath' => 'sites/default/files/onc9991112720001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '23931',
        'status' => '1',
        'timestamp' => '1363895308',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13274',
        'uid' => '5392',
        'filename' => 'onc9991112720002.jpg',
        'filepath' => 'sites/default/files/onc9991112720002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '10588',
        'status' => '1',
        'timestamp' => '1363895308',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13275',
        'uid' => '5392',
        'filename' => 'onc9991112720003.jpg',
        'filepath' => 'sites/default/files/onc9991112720003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '16827',
        'status' => '1',
        'timestamp' => '1363895308',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363895308',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '57630',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363895056',
    'changed' => '1367357276',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '57630',
    'revision_uid' => '1',
    'title' => 'article1_na_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367357276',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13271',
        'uid' => '5392',
        'filename' => 'article1_0313.html',
        'filepath' => 'sites/default/files/article1_0313.html',
        'filemime' => 'text/html',
        'filesize' => '18838',
        'status' => '1',
        'timestamp' => '1363895056',
        'origname' => '',
        'list' => '1',
        'data' => NULL,
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Squamous Cell Carcinomas of the Tongue and Oral Cavity as Secondary Malignancies: What Factors Are Implicated?',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The pegylated liposomal doxorubicin (PLD) was introduced clinically in the 1990s and won FDA approvals for the treatment of Kaposi\'s sarcoma (1995) and ovarian cancer (2000). Its attenuated toxicities compared with "free" doxorubicin led to strategies of long-term maintenance in Kaposi\'s sarcoma (KS) [1,2 ] and, subsequently, was adopted in our trials for recurrent ovarian cancers. In 2007, the report of Andreopoulou et al. summarized our experience in 16 patients, with seven continuing beyond 4 years without progression of disease; none had stopped the drug because of toxicities, although skin manifestations led to gradually extending treatment intervals up to 8 weeks and some dose reductions',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Franco Muggia',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '18838',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => array(
        'fid' => '13682',
        'uid' => '5392',
        'filename' => 'article1_na_0313.html',
        'filepath' => 'sites/default/files/article1_na_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '19896',
        'status' => '1',
        'timestamp' => '1366921493',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363895056',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56989',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363282025',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56989',
    'revision_uid' => '1',
    'title' => 'cp_ascogu_article6_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13188',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article6_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article6_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '13962',
        'status' => '1',
        'timestamp' => '1363292251',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Interview with Dr. Jason Efstathiou',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Several themes emerged from the 2013 Genitourinary (GU) Cancers Symposium spanning the full spectrum of prostate cancer, ranging from active surveillance for lower-risk prostate cancer to the timing and sequencing of novel targeted therapy for advanced or metastatic disease. Jason Efstathiou, MD, DPhil, Department of Radiation Oncology at Massachusetts General Hospital and Harvard Medical School in Boston, spoke with The Oncologist about new findings of special interest to clinicians in community oncology practice. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '13962',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363282025',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56987',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363281955',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56987',
    'revision_uid' => '1',
    'title' => 'cp_ascogu_article5_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/cpascoguarticle50313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13177',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article5_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article5_0313.html',
        'filemime' => 'text/html',
        'filesize' => '10908',
        'status' => '1',
        'timestamp' => '1363281955',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Clinical Staging Underestimates Pathological Stage for Many Bladder Cancers',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Determining the clinical stage of bladder cancer on the basis of presurgical features alone is highly inaccurate, with a discrepancy rate of 47.8% compared with pathologic staging following radical cystectomy, according to a new analysis of bladder cancer staging data in the National Cancer Data Base.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '10908',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363281955',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56986',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363281898',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56986',
    'revision_uid' => '1',
    'title' => 'cp_ascogo_article4_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13190',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article4_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article4_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '5094',
        'status' => '1',
        'timestamp' => '1363292292',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Adjuvant Radiotherapy Following Radical Prostatectomy Improves Long-Term Biochemical Control with Few Late Side Effects',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Radiation therapy following radical prostatectomy safely improves long-term biochemical control compared with a wait-and-see approach in men with pathologic T3 (pT3) prostate cancer, according to new findings that add to a growing evidence base in support of adjuvant radiotherapy.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '5094',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363281898',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56985',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363281840',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56985',
    'revision_uid' => '1',
    'title' => 'CP_ascogu_article3_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/cpascoguarticle30313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13175',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article3_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article3_0313.html',
        'filemime' => 'text/html',
        'filesize' => '5614',
        'status' => '1',
        'timestamp' => '1363281840',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Androgen Blockade Can Be Shortened by Half in Patients With High-Risk Prostate Cancer Treated With Pelvic Radiation',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Androgen blockade can be safely reduced from 36 to 18 months in combination with standard pelvic radiotherapy without compromising outcomes in patients with localized high-risk prostate cancer. Evaluated in context with other recent studies of androgen suppression, these findings suggest an optimal treatment duration of 18 months, beyond which no additional survival benefit is gained.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '5614',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363281840',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56702',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363026515',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56702',
    'revision_uid' => '1',
    'title' => 'sctm_article9_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle90313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13121',
        'uid' => '5392',
        'filename' => 'sctm_article9_0313.html',
        'filepath' => 'sites/default/files/sctm_article9_0313.html',
        'filemime' => 'text/html',
        'filesize' => '58835',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Notch signaling mediates breast cancer cell survival and chemoresistance. In this report, we aimed to evaluate the antitumor efficacy of PF-03084014 in combination with docetaxel in triple-negative breast cancer models. The mechanism of action was investigated. PF-03084014 significantly enhanced the antitumor activity of docetaxel in multiple xenograft models including HCC1599, MDA-MB-231Luc, and AA1077. Docetaxel activated the Notch pathway by increasing the cleaved Notch1 intracellular domain and suppressing the endogenous Notch inhibitor NUMB. PF-03084014 used in combination with docetaxel reversed these effects and demonstrated early-stage synergistic apoptosis. Docetaxel elicited chemoresistance by elevating cytokine release and expression of survivin and induced an endothelial mesenchymal transition (EMT) phenotype by increasing the expressions of Snail, Slug, and N-cadherin. When reimplanted, the docetaxel-residual cells not only became much more tumorigenic, as evidenced by a higher fraction of tumor-initiating cells (TICs), but also showed higher metastatic potential compared with nontreated cells, leading to significantly shortened survival. In contrast, PF-03084014 was able to suppress expression of survivin and MCL1, reduce ABCB1 and ABCC2, upregulate BIM, reverse the EMT phenotype, and diminish the TICs. Additionally, the changes to the ALDH+ and CD133+/CD44+ subpopulations following therapy corresponded with the TIC self-renewal assay outcome. In summary, PF-03084014 demonstrated synergistic effects with docetaxel through multiple mechanisms. This work provides a strong preclinical rationale for the clinical utility of PF-03084014 to improve taxane therapy. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Cathy C. Zhang, Zhengming Yan, Qing Zong, Douglas D. Fang, Cory Painter, Qin Zhang, Enhong Chen, Maruja E. Lira, Annette John-Baptiste, James G. Christensen',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '465572',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13115',
        'uid' => '5392',
        'filename' => 'sct0031301290001.jpg',
        'filepath' => 'sites/default/files/sct0031301290001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '73708',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13116',
        'uid' => '5392',
        'filename' => 'sct0031301290002.jpg',
        'filepath' => 'sites/default/files/sct0031301290002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '77465',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13117',
        'uid' => '5392',
        'filename' => 'sct0031301290003.jpg',
        'filepath' => 'sites/default/files/sct0031301290003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '57580',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13118',
        'uid' => '5392',
        'filename' => 'sct0031301290004.jpg',
        'filepath' => 'sites/default/files/sct0031301290004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '75934',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13119',
        'uid' => '5392',
        'filename' => 'sct0031301290005.jpg',
        'filepath' => 'sites/default/files/sct0031301290005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '57579',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13120',
        'uid' => '5392',
        'filename' => 'sct0031301290006.jpg',
        'filepath' => 'sites/default/files/sct0031301290006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '64471',
        'status' => '1',
        'timestamp' => '1363026515',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363026515',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56701',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363026260',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56701',
    'revision_uid' => '1',
    'title' => 'sctm_article8_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle80313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13114',
        'uid' => '5392',
        'filename' => 'sctm_article8_0313.html',
        'filepath' => 'sites/default/files/sctm_article8_0313.html',
        'filemime' => 'text/html',
        'filesize' => '60920',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Quantitative Microplate Assay for Studying Mesenchymal Stromal Cell-Induced Neuropoiesis',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Transplanting mesenchymal stromal cells (MSCs) or their derivatives in a neurodegenerative environment is believed to be beneficial because of the trophic support, migratory guidance, and neurogenic stimuli they provide. There is a growing need for in vitro models of mesenchymal-neural cell interactions to enable identification of mediators of the MSC activity and quantitative assessment of neuropoietic potency of MSC preparations. Here, we characterize a microplate-format coculture system in which primary embryonic rat cortex cells are directly cocultured with human MSCs on cell-derived extracellular matrix (ECM) in the absence of exogenous growth factors. In this system, expression levels of the rat neural stem/early progenitor marker nestin, as well as neuronal and astrocytic markers, directly depended on MSC dose, whereas an oligodendrogenic marker exhibited a biphasic MSC-dose response, as measured using species-specific quantitative reverse transcription-polymerase chain reaction in total cell lysates and confirmed using immunostaining. Both neural cell proliferation and differentiation contributed to the MSC-mediated neuropoiesis. ECM\'s heparan sulfate proteoglycans were essential for the growth of the nestin-positive cell population. Neutralization studies showed that MSC-derived fibroblast growth factor 2 was a major and diffusible inducer of rat nestin, whereas MSC-derived bone morphogenetic proteins (BMPs), particularly, BMP4, were astrogenesis mediators, predominantly acting in a coculture setting. This system enables analysis of multifactorial MSC-neural cell interactions and can be used for elucidating the neuropoietic potency of MSCs and their derivative preparations. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Irina Aizman, Michael McGrogan, Casey C. Case',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '349404',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13107',
        'uid' => '5392',
        'filename' => 'sct0031301310001.jpg',
        'filepath' => 'sites/default/files/sct0031301310001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '30829',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13108',
        'uid' => '5392',
        'filename' => 'sct0031301310002.jpg',
        'filepath' => 'sites/default/files/sct0031301310002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '35846',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13109',
        'uid' => '5392',
        'filename' => 'sct0031301310003.jpg',
        'filepath' => 'sites/default/files/sct0031301310003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '21552',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13110',
        'uid' => '5392',
        'filename' => 'sct0031301300005.jpg',
        'filepath' => 'sites/default/files/sct0031301300005_0.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '125695',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13111',
        'uid' => '5392',
        'filename' => 'sct0031301310004.jpg',
        'filepath' => 'sites/default/files/sct0031301310004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '37926',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13112',
        'uid' => '5392',
        'filename' => 'sct0031301310006.jpg',
        'filepath' => 'sites/default/files/sct0031301310006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '11702',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '6' => array(
        'fid' => '13113',
        'uid' => '5392',
        'filename' => 'sct0031301310007.jpg',
        'filepath' => 'sites/default/files/sct0031301310007.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '24934',
        'status' => '1',
        'timestamp' => '1363026259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363026260',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56700',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363026131',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56700',
    'revision_uid' => '1',
    'title' => 'sctm_article7_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle70313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13106',
        'uid' => '5392',
        'filename' => 'sctm_article7_0313.html',
        'filepath' => 'sites/default/files/sctm_article7_0313.html',
        'filemime' => 'text/html',
        'filesize' => '40986',
        'status' => '1',
        'timestamp' => '1363026131',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Meeting Report: Using Stem Cells for Biological and Therapeutics Discovery in Mental Illness, April 2012 ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'This report synthesizes the discussions during a workshop convened April 24-25, 2012, by the National Institute of Mental Health and the Foundation for the NIH in Bethesda, Maryland, that focused on progress and challenges in the use of patient-derived reprogrammed cells for basic biological discovery, target identification, screening, and drug development for mental illnesses such as schizophrenia, bipolar disorder, and autism spectrum disorders. The workshop revealed that the greatest progress has been made in reprogramming methods and agreed-upon standards for validating the resulting induced pluripotent stem cell lines. However, challenges remain in several areas, including efficiently generating and validating specific neural cell types with respect to regional identity, establishing assays with predictive validity to mental illness pathophysiology, and generating sufficient statistical power and data reproducibility across laboratories. A brainstorming session yielded a number of suggestions, including calls to (a) facilitate the replication of results by standardizing protocols and samples used across laboratories; (b) improve technology by generating cheaper/faster targeting methods, reporters, and assays; and (c) improve resource sharing and collaboration, with an emphasis on rapid sharing of new cell lines, technologies, and best practices, possibly incorporated into a public-private partnership. The meeting provided an important venue for academic, government, and private sector scientists to address potential opportunities for translational and clinical applications of reprogrammed cell research. A number of activities since the workshop have reflected the feedback from meeting participants. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'David M. Panchision',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '40986',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363026131',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56699',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363025918',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56699',
    'revision_uid' => '1',
    'title' => 'sctm_article6_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle60313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13105',
        'uid' => '5392',
        'filename' => 'sctm_article6_0313.html',
        'filepath' => 'sites/default/files/sctm_article6_0313.html',
        'filemime' => 'text/html',
        'filesize' => '72491',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Safety of Epicenter Versus Intact Parenchyma as a Transplantation Site for Human Neural Stem Cells for Spinal Cord Injury Therapy ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Neural stem cell transplantation may have the potential to yield repair and recovery of function in central nervous system injury and disease, including spinal cord injury (SCI). Multiple pathological processes are initiated at the epicenter of a traumatic spinal cord injury; these are generally thought to make the epicenter a particularly hostile microenvironment. Conversely, the injury epicenter is an appealing potential site of therapeutic human central nervous system-derived neural stem cell (hCNS-SCns) transplantation because of both its surgical accessibility and the avoidance of spared spinal cord tissue. In this study, we compared hCNS-SCns transplantation into the SCI epicenter (EPI) versus intact rostral/caudal (R/C) parenchyma in contusion-injured athymic nude rats, and assessed the cell survival, differentiation, and migration. Regardless of transplantation site, hCNS-SCns survived and proliferated; however, the total number of hCNS-SCns quantified in the R/C transplant animals was twice that in the EPI animals, demonstrating increased overall engraftment. Migration and fate profile were unaffected by transplantation site. However, although transplantation site did not alter the proportion of human astrocytes, EPI transplantation shifted the localization of these cells and exhibited a correlation with calcitonin gene-related peptide fiber sprouting. Critically, no changes in mechanical allodynia or thermal hyperalgesia were observed. Taken together, these data suggest that the intact parenchyma may be a more favorable transplantation site than the injury epicenter in the subacute period post-SCI. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Katja M. Piltti, Desirée L. Salazar, Nobuko Uchida, Brian J. Cummings, Aileen J. Anderson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '482324',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13098',
        'uid' => '5392',
        'filename' => 'sct0031301300001.jpg',
        'filepath' => 'sites/default/files/sct0031301300001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '65767',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13099',
        'uid' => '5392',
        'filename' => 'sct0031301300003.jpg',
        'filepath' => 'sites/default/files/sct0031301300003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '26665',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13100',
        'uid' => '5392',
        'filename' => 'sct0031301300002.jpg',
        'filepath' => 'sites/default/files/sct0031301300002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '30722',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13101',
        'uid' => '5392',
        'filename' => 'sct0031301300004.jpg',
        'filepath' => 'sites/default/files/sct0031301300004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '80816',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13102',
        'uid' => '5392',
        'filename' => 'sct0031301300005.jpg',
        'filepath' => 'sites/default/files/sct0031301300005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '125695',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13103',
        'uid' => '5392',
        'filename' => 'sct0031301300006.jpg',
        'filepath' => 'sites/default/files/sct0031301300006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '41728',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '6' => array(
        'fid' => '13104',
        'uid' => '5392',
        'filename' => 'sct0031301300007.jpg',
        'filepath' => 'sites/default/files/sct0031301300007.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '38440',
        'status' => '1',
        'timestamp' => '1363025918',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363025918',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56698',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363025723',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56698',
    'revision_uid' => '1',
    'title' => 'sctm_article5_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle50313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13097',
        'uid' => '5392',
        'filename' => 'actm_article5_0313.html',
        'filepath' => 'sites/default/files/actm_article5_0313.html',
        'filemime' => 'text/html',
        'filesize' => '26484',
        'status' => '1',
        'timestamp' => '1363025723',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Separation by Cell Size Enriches for Mammary Stem Cell Repopulation Activity ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Mammary gland reconstitution experiments, as well as lineage tracing experiments, have provided evidence for the existence of adult mammary stem cells (MaSCs). In addition, cell sorting techniques for specific cell surface markers (CD24+CD29HCD49fHSca1-) have been used to prospectively isolate MaSC-enriched populations. Although these markers enrich for cell subpopulations that harbor MaSCs, they do not identify regenerative stem cells uniquely. Here, we report that MaSCs can be further defined by the property of cell size. Fluorescence-activated cell sorting was used to analyze sizing beads and further separate populations of cells with varying degrees of forward scatter (FSC). Cells with a low FSC that were approximately <10 µm in size lacked outgrowth potential and failed to reconstitute the mammary gland when transplanted into the cleared fat pads of syngeneic mice. In contrast, cells >10 µm in size with a higher FSC had increased outgrowth potential as compared with lineage-negative (LIN-) control cells. Limiting dilution transplantation assays indicated that the repopulating ability of LIN-CD24+CD29H cells that were >10 µm in size was significantly increased as compared with cells marked by CD24 and CD29 alone. These results suggest that MaSCs can be further isolated by sorting based on size/FSC. These findings have critical implications for understanding mammary gland stem cell biology, an important requisite step for understanding the etiology of breast cancer. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Heather L. Machado, Frances S. Kittrell, David Edwards, Amanda N. White, Rachel L. Atkinson, Jeffrey M. Rosen, Daniel Medina, Michael T. Lewis',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '110528',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13095',
        'uid' => '5392',
        'filename' => 'sct0031301320001.jpg',
        'filepath' => 'sites/default/files/sct0031301320001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '39066',
        'status' => '1',
        'timestamp' => '1363025723',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13096',
        'uid' => '5392',
        'filename' => 'sct0031301320002.jpg',
        'filepath' => 'sites/default/files/sct0031301320002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '44978',
        'status' => '1',
        'timestamp' => '1363025723',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363025723',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56697',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363025481',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56697',
    'revision_uid' => '1',
    'title' => 'sctm_article4_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle40313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13094',
        'uid' => '5392',
        'filename' => 'sctm_article4_0313.html',
        'filepath' => 'sites/default/files/sctm_article4_0313.html',
        'filemime' => 'text/html',
        'filesize' => '77391',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Subventricular Zone-Derived Neural Stem Cell Grafts Protect Against Hippocampal Degeneration and Restore Cognitive Function in the Mouse Following Intrahippocampal Kainic Acid Administration ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Temporal lobe epilepsy (TLE) is a major neurological disease, often associated with cognitive decline. Since approximately 30% of patients are resistant to antiepileptic drugs, TLE is being considered as a possible clinical target for alternative stem cell-based therapies. Given that insulin-like growth factor I (IGF-I) is neuroprotective following a number of experimental insults to the nervous system, we investigated the therapeutic potential of neural stem/precursor cells (NSCs) transduced, or not, with a lentiviral vector for overexpression of IGF-I after transplantation in a mouse model of kainic acid (KA)-induced hippocampal degeneration, which represents an animal model of TLE. Exposure of mice to the Morris water maze task revealed that unilateral intrahippocampal NSC transplantation significantly prevented the KA-induced cognitive decline. Moreover, NSC grafting protected against neurodegeneration at the cellular level, reduced astrogliosis, and maintained endogenous granule cell proliferation at normal levels. In some cases, as in the reduction of hippocampal cell loss and the reversal of the characteristic KA-induced granule cell dispersal, the beneficial effects of transplanted NSCs were manifested earlier and were more pronounced when these were transduced to express IGF-I. However, differences became less pronounced by 2 months postgrafting, since similar amounts of IGF-I were detected in the hippocampi of both groups of mice that received cell transplants. Grafted NSCs survived, migrated, and differentiated into neurons--including glutamatergic cells--and not glia, in the host hippocampus. Our results demonstrate that transplantation of IGF-I producing NSCs is neuroprotective and restores cognitive function following KA-induced hippocampal degeneration. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Panagiota Miltiadous,,* Georgia Kouroupi,,* Antonios Stamatakis, Paraskevi N. Koutsoudaki, Rebecca Matsas, Fotini Stylianopoulou',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '636737',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13086',
        'uid' => '5392',
        'filename' => 'sct0031301350001.jpg',
        'filepath' => 'sites/default/files/sct0031301350001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '28814',
        'status' => '1',
        'timestamp' => '1363025380',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13087',
        'uid' => '5392',
        'filename' => 'sct0031301350002.jpg',
        'filepath' => 'sites/default/files/sct0031301350002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '71093',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13088',
        'uid' => '5392',
        'filename' => 'sct0031301350003.jpg',
        'filepath' => 'sites/default/files/sct0031301350003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '38115',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13089',
        'uid' => '5392',
        'filename' => 'sct0031301350004.jpg',
        'filepath' => 'sites/default/files/sct0031301350004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '66510',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13090',
        'uid' => '5392',
        'filename' => 'sct0031301350005.jpg',
        'filepath' => 'sites/default/files/sct0031301350005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '164704',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13091',
        'uid' => '5392',
        'filename' => 'sct0031301350006.jpg',
        'filepath' => 'sites/default/files/sct0031301350006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '72153',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '6' => array(
        'fid' => '13092',
        'uid' => '5392',
        'filename' => 'sct0031301350007.jpg',
        'filepath' => 'sites/default/files/sct0031301350007.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '117529',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '7' => array(
        'fid' => '13093',
        'uid' => '5392',
        'filename' => 'sct0031301350008.jpg',
        'filepath' => 'sites/default/files/sct0031301350008.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '428',
        'status' => '1',
        'timestamp' => '1363025481',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363025481',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56696',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363025259',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56696',
    'revision_uid' => '1',
    'title' => 'sctm_article3_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle30313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13085',
        'uid' => '5392',
        'filename' => 'sctm_article3_0313.html',
        'filepath' => 'sites/default/files/sctm_article3_0313.html',
        'filemime' => 'text/html',
        'filesize' => '73720',
        'status' => '1',
        'timestamp' => '1363025259',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Concise Review: New Paradigms for Down Syndrome Research Using Induced Pluripotent Stem Cells: Tackling Complex Human Genetic Disease ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Down syndrome (DS) is a complex developmental disorder with diverse pathologies that affect multiple tissues and organ systems. Clear mechanistic description of how trisomy of chromosome 21 gives rise to most DS pathologies is currently lacking and is limited to a few examples of dosage-sensitive trisomic genes with large phenotypic effects. The recent advent of cellular reprogramming technology offers a promising way forward, by allowing derivation of patient-derived human cell types in vitro. We present general strategies that integrate genomics technologies and induced pluripotent stem cells to identify molecular networks driving different aspects of DS pathogenesis and describe experimental approaches to validate the causal requirement of candidate network defects for particular cellular phenotypes. This overall approach should be applicable to many poorly understood complex human genetic diseases, whose pathogenic mechanisms might involve the combined effects of many genes. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'James A. Briggs, Elizabeth A. Mason, Dmitry A. Ovchinnikov, Christine A. Wells, Ernst J. Wolvetang',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '186836',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13083',
        'uid' => '5392',
        'filename' => 'sct0031301330001.jpg',
        'filepath' => 'sites/default/files/sct0031301330001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '61032',
        'status' => '1',
        'timestamp' => '1363025259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13084',
        'uid' => '5392',
        'filename' => 'sct0031301330002.jpg',
        'filepath' => 'sites/default/files/sct0031301330002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '52084',
        'status' => '1',
        'timestamp' => '1363025259',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363025259',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56695',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363025058',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56695',
    'revision_uid' => '1',
    'title' => 'sctm_article2_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle20313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13082',
        'uid' => '5392',
        'filename' => 'sctm_article2_0313.html',
        'filepath' => 'sites/default/files/sctm_article2_0313.html',
        'filemime' => 'text/html',
        'filesize' => '43277',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Neural Progenitors Derived From Human Induced Pluripotent Stem Cells Survive and Differentiate Upon Transplantation Into a Rat Model of Amyotrophic Lateral Sclerosis ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Human induced pluripotent stem cells (iPSCs) offer hope for personalized regenerative cell therapy in amyotrophic lateral sclerosis (ALS). We analyzed the fate of human iPSC-derived neural progenitors transplanted into the spinal cord of wild-type and transgenic rats carrying a human mutated SOD1(G93A) gene. The aim was to follow survival and differentiation of human neural progenitors until day 60 post-transplantation in two different in vivo environments, one being ALS-like. iPSC-derived neural progenitors efficiently engrafted in the adult spinal cord and survived at high numbers. Different neural progenitor, astroglial, and neuronal markers indicated that, over time, the transplanted nestin-positive cells differentiated into cells displaying a neuronal phenotype in both wild-type and transgenic SOD1 rats. Although a transient microglial phenotype was detected at day 15, astroglial staining was negative in engrafted cells from day 1 to day 60. At day 30, differentiation toward a neuronal phenotype was identified, which was further established at day 60 by the expression of the neuronal marker MAP2. A specification process into motoneuron-like structures was evidenced in the ventral horns in both wild-type and SOD1 rats. Our results demonstrate proof-of-principle of survival and differentiation of human iPSC-derived neural progenitors in in vivo ALS environment, offering perspectives for the use of iPSC-based therapy in ALS. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Iuliana Ristea Popescu, Charles Nicaise, Song Liu, Grégoire Bisch, Sarah Knippenberg, Valery Daubie, Delphine Bohl, Roland Pochet,',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '367288',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13076',
        'uid' => '5392',
        'filename' => 'sct0031301280001.jpg',
        'filepath' => 'sites/default/files/sct0031301280001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '59073',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13077',
        'uid' => '5392',
        'filename' => 'sct0031301280002.jpg',
        'filepath' => 'sites/default/files/sct0031301280002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '115698',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13078',
        'uid' => '5392',
        'filename' => 'sct0031301280003.jpg',
        'filepath' => 'sites/default/files/sct0031301280003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34133',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13079',
        'uid' => '5392',
        'filename' => 'sct0031301280004.jpg',
        'filepath' => 'sites/default/files/sct0031301280004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '43456',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '4' => array(
        'fid' => '13080',
        'uid' => '5392',
        'filename' => 'sct0031301280005.jpg',
        'filepath' => 'sites/default/files/sct0031301280005.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '20905',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '5' => array(
        'fid' => '13081',
        'uid' => '5392',
        'filename' => 'sct0031301280006.jpg',
        'filepath' => 'sites/default/files/sct0031301280006.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '50746',
        'status' => '1',
        'timestamp' => '1363025058',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363025058',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56694',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1363024860',
    'changed' => '1367361162',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56694',
    'revision_uid' => '1',
    'title' => 'sctm_article1_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361162',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/sctmarticle10313',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13075',
        'uid' => '5392',
        'filename' => 'actm_article1_0313.html',
        'filepath' => 'sites/default/files/actm_article1_0313.html',
        'filemime' => 'text/html',
        'filesize' => '23676',
        'status' => '1',
        'timestamp' => '1363024842',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Modeling Human Protein Aggregation Cardiomyopathy Using Murine Induced Pluripotent Stem Cells ',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'Several mutations in αB-crystallin (CryAB), a heat shock protein with chaperone-like activities, are causally linked to skeletal and cardiac myopathies in humans. To better understand the underlying pathogenic mechanisms, we had previously generated transgenic (TG) mice expressing R120GCryAB, which recapitulated distinguishing features of the myopathic disorder (e.g., protein aggregates, hypertrophic cardiomyopathy). To determine whether induced pluripotent stem cell (iPSC)-derived cardiomyocytes, a new experimental approach for human disease modeling, would be relevant to aggregation-prone disorders, we decided to exploit the existing transgenic mouse model to derive iPSCs from tail tip fibroblasts. Several iPSC lines were generated from TG and non-TG mice and validated for pluripotency. TG iPSC-derived cardiomyocytes contained perinuclear aggregates positive for CryAB staining, whereas CryAB protein accumulated in both detergent-soluble and insoluble fractions. iPSC-derived cardiomyocytes identified by cardiac troponin T staining were significantly larger when expressing R120GCryAB at a high level in comparison with TG low expressor or non-TG cells. Expression of fetal genes such as atrial natriuretic factor, B-type natriuretic peptide, and α-skeletal α-actin, assessed by quantitative reverse transcription-polymerase chain reaction, were increased in TG cardiomyocytes compared with non-TG, indicating the activation of the hypertrophic genetic program in vitro. Our study demonstrates for the first time that differentiation of R120G iPSCs into cardiomyocytes causes protein aggregation and cellular hypertrophy, recapitulating in vitro key pathognomonic hallmarks found in both animal models and patients. Our findings pave the way for further studies exploiting this cell model system for mechanistic and therapeutic investigations. ',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Pattraranee Limphong, Huali Zhang, Elisabeth Christians, Qiang Liu, Michael Riedel, Kathryn Ivey, Paul Cheng, Katie Mitzelfelt, Graydon Taylor, Dennis Winge, Deepak Srivastava, Ivor Benjamin',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '322875',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => array(
        'fid' => '13071',
        'uid' => '5392',
        'filename' => 'sct0031301340001.jpg',
        'filepath' => 'sites/default/files/sct0031301340001.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '118244',
        'status' => '1',
        'timestamp' => '1363024841',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '1' => array(
        'fid' => '13072',
        'uid' => '5392',
        'filename' => 'sct0031301340002.jpg',
        'filepath' => 'sites/default/files/sct0031301340002.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '97030',
        'status' => '1',
        'timestamp' => '1363024841',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '2' => array(
        'fid' => '13073',
        'uid' => '5392',
        'filename' => 'sct0031301340003.jpg',
        'filepath' => 'sites/default/files/sct0031301340003.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '48941',
        'status' => '1',
        'timestamp' => '1363024841',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
      '3' => array(
        'fid' => '13074',
        'uid' => '5392',
        'filename' => 'sct0031301340004.jpg',
        'filepath' => 'sites/default/files/sct0031301340004.jpg',
        'filemime' => 'image/jpeg',
        'filesize' => '34984',
        'status' => '1',
        'timestamp' => '1363024842',
        'origname' => '',
        'list' => '1',
        'data' => array(
          'alt' => '',
          'title' => '',
        ),
      ),
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'sctm.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1363024860',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56494',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1362777579',
    'changed' => '1367361161',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56494',
    'revision_uid' => '1',
    'title' => 'CP_ASCOGU_article2_0313',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361161',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13189',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article2_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article2_0313_0.html',
        'filemime' => 'text/html',
        'filesize' => '5398',
        'status' => '1',
        'timestamp' => '1363292269',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'One-Third of Localized Prostate Cancers Gleason Upgraded During Active Surveillance',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'During long-term active surveillance, approximately one-third of localized prostate cancers will be pathologically upgraded, according to new findings from a prospective registry of active surveillance. These findings underscore the importance of repeat prostate biopsies to detect early progression on active surveillance and, if necessary, to switch to active treatment.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '5398',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1362777579',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56393',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1362693493',
    'changed' => '1367361162',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56393',
    'revision_uid' => '1',
    'title' => 'CP_ASCOGU_article1_0312',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361162',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'path' => 'content/cpascoguarticle10312',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13055',
        'uid' => '5392',
        'filename' => 'cp_ascogu_article1_0313.html',
        'filepath' => 'sites/default/files/cp_ascogu_article1_0313.html',
        'filemime' => 'text/html',
        'filesize' => '5723',
        'status' => '1',
        'timestamp' => '1362693493',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => '2013 GU Cancers Symposium Overview',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'The 2013 Genitourinary Cancers Symposium, held February 14-16, 2013, in Orlando, Florida, focused on multidisciplinary approaches to the prevention, screening, evaluation, and management of genitourinary (GU) cancers. The meeting was cosponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO), and provided updates on treatment advances in urothelial carcinoma, and prostate, penile, urethral, testicular, and renal cancers.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Anne Jacobson',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '5723',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1362693493',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
    array(
    'nid' => '56289',
    'type' => 'page_html',
    'language' => '',
    'uid' => '5392',
    'status' => '1',
    'created' => '1362599416',
    'changed' => '1367361162',
    'comment' => '0',
    'promote' => '1',
    'moderate' => '0',
    'sticky' => '0',
    'tnid' => '0',
    'translate' => '0',
    'vid' => '56289',
    'revision_uid' => '1',
    'title' => 'europers1_0213',
    'body' => '',
    'teaser' => '',
    'log' => '',
    'revision_timestamp' => '1367361162',
    'format' => '0',
    'name' => 'lauren.deans@alphamedpress.com',
    'picture' => '',
    'data' => 'a:1:{s:7:"contact";i:0;}',
    'field_htmlfile' => array(
      '0' => array(
        'fid' => '13037',
        'uid' => '5392',
        'filename' => 'europers1_0213.html',
        'filepath' => 'sites/default/files/europers1_0213_0.html',
        'filemime' => 'text/html',
        'filesize' => '20619',
        'status' => '1',
        'timestamp' => '1362602668',
        'origname' => '',
        'list' => '1',
        'data' => array(),
      ),
    ),
    'field_article_title' => array(
      '0' => array(
        'value' => 'Challenges in Oncology: From Clinical Trials to Introducing New Drugs to the Clinic',
      ),
    ),
    'field_abstract' => array(
      '0' => array(
        'value' => 'A greater understanding of disease biology and the development of new therapeutic approaches with increasing efficacy, has led to significant improvements in breast cancer care over the last decade [1]. The process of introducing a new drug into the clinic can, however, be a complex process, from the perspective of clinical trial design and implementation, drug approval and reimbursement. While the current and future potential of targeted therapy is compelling, it must also be acknowledged that in the present economic climate, there is a critical need for consideration of cost-effectiveness, both in the trial setting and when the drug or therapeutic intervention is introduced as a standard of care. Tailoring of clinical trial design approaches may increase both efficacy and efficiency and also help reduce the economic costs to the Clinical Trials Unit (CTU). Maximising accrual to cancer clinical trials also needs to be prioritised, particularly among minority groups. Once the drug or therapeutic approach has been approved, the issue of cost remains a challenging one, with significant global variation in the reimbursement of publicly funded cancer drugs.',
      ),
    ),
    'field_authors' => array(
      '0' => array(
        'value' => 'Maureen E. Trudeau, Ciara M. Kelly, Lillian Smyth, Cathy Kelly, Mark Lawler',
      ),
    ),
    'field_htmlpage_downloadsize' => array(
      '0' => array(
        'value' => '20619',
      ),
    ),
    'field_bannerhtmlfile' => array(
      '0' => NULL,
    ),
    'field_inject_category' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_embeddedimage' => array(
      '0' => NULL,
    ),
    'field_embeddedfiles' => array(
      '0' => NULL,
    ),
    'field_content_bydomain' => array(
      '0' => array(
        'value' => 'oncologisthd.ampserver.intstrux.com',
      ),
    ),
    'field_multisite_featured' => array(
      '0' => array(
        'value' => '0',
      ),
    ),
    'field_multisite_weight' => array(
      '0' => array(
        'value' => NULL,
      ),
    ),
    'last_comment_timestamp' => '1362599416',
    'last_comment_name' => NULL,
    'comment_count' => '0',
    'taxonomy' => array(),
    'nodewords' => array(),
    'menu' => array(
      'link_title' => '',
      'mlid' => 0,
      'plid' => 0,
      'menu_name' => 'primary-links',
      'weight' => 0,
      'options' => array(),
      'module' => 'menu',
      'expanded' => 0,
      'hidden' => 0,
      'has_children' => 0,
      'customized' => 0,
      'parent_depth_limit' => 8,
    ),
    'export_display' => '$display = new ;
$display->layout = \'\';
$display->layout_settings = \'\';
$display->panel_settings = \'\';
$display->cache = \'\';
$display->title = \'\';
$display->content = array();
$display->panels = array();
$display->hide_title = PANELS_TITLE_FIXED;
$display->title_pane = \'0\';
',
    '#_export_node_encode_object' => '1',
  ),
);
}